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ABSTRACT 
Lactic acid bacteria (LAB) have been recognized to be a probiotic microorganism 
for human health. Cyclic dipeptides (CDPs) produced by LAB are important for their 
antibiotic activities. CDPs were a group of molecules with several kinds of 
diketopiperazine structure and have served as attractive scaffolds for drug design. 
However, the entire pool of CDPs from a given lactic acid bacterial culture is not fully 
understood. The present study identified the CDPs produced by Lactobacillus plantarum 
LBP-K10, which was the most potent antimicrobial isolates from Korean kimchi. 
Totally, seven CDPs were identified through gas chromatography-mass spectroscopy. 
Additionally this study provided a new method for purifying a massive amount of the 
complete set of CDPs from culture filtrates (CFs) of Lb. plantarum LBP-K10 by using 
the anion exchange resin Amberlite IRA-67 or Purolite A420S. The set of all CDPs 
showed remarkable potency with bioactivities against multidrug-resistant bacteria, 
pathogenic fungi and influenza virus compared with the activities of single CDP. 
Recently, studies revealed lactic acid bacteria or its products might capable of 
inhibiting cancer progression by several mechanisms. However, most of studies focus 
on gastrointestinal (GI) tract related cancer, especially colon cancer. The effect of lactic 
acid bacteria or its related products on non-GI tract cancer was rarely examined. Since 
studies proved the effectively absorbing of CDPs, the cancer prevention effect lactic acid 
bacteria on a kind of non-GI tract cancer, breast cancer was investigated. A special 
ii 
 
methylene chloride extracted fraction (MC-K10) was identified, which mainly contained 
several CDPs from Lb. plantarum LBP-K10 culture filtrates (CF-K10). In this study, it 
was firstly proved that oral applying CF-K10 inhibited the progression of breast cancer 
growth in animal model. We further discovered that CF-K10 and MC-K10 might induce 
apoptosis in MDA-MB-231 cells. Moreover, it was demonstrated MC-K10 and 
cyclo(Phe-Pro) can impair the stemness and self-renew of cancer stem cells. These 
studies provide a new insight for the probiotic actives of LAB and its products, as well 
as give a hint for developing breast cancer prevention strategy. 
The importance and benefit of the CDPs on human heath encouraged us to 
investigate the cyclic dipeptide biosynthesis process. By ninhydrin activity staining, it 
was confirmed bioactive cyclic dipeptides synthesized in by Lb. plantarum LBP-K10 
through cyclic dipeptide synthase (CDPS) dependent pathway. Then this CDPS were 
purified and characterized by 2D LC/MS analysis as a 26.1 kDa novel protein (accession 
number: gi311821850). The 690 bp gene sequence of this 26.1 kDa protein was also 
obtained from NCBI genome database. Interestingly, after transfected this gene into E. 
coli, the content of several proline base cyclic dipeptides was increased. When subjected 
to in vitro reaction conditions, CDPS helped to generate several cyclic dipeptides. To 
better understand that the mechanism of cyclic dipeptides synthesis in molecular level, 
X-ray analysis of CDPS was performed. CDPS was composed as a tetramer structure 
with 4 identical subunit showed in the ribbon model. This study for the first time 
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identified a novel CDPS and defined in vitro reaction conditions based on CDPs for 
generating CDPs. This study will help to understand cyclic dipeptides synthesis 
mechanism and producing nature antibiotic cyclic dipeptides in vitro through 
biosynthesis reactor. 
Above of all, these studies identified the entire CDPs profile in MC extract fraction 
of Lb. plantarum LPB-K10, proved the cancer prevention effect of LAB and its produced 
CDPs, and for the first identified a novel CDPS. This study provided new insight on the 
probiotic LAB and benefit for understanding CDPs biosynthesis mechanisms. 
Key words: Cyclic dipeptides; Cyclic dipeptide synthase; Antibiotic activity; 
Lactobacillus plantarum; Breast cancer; Cancer prevention; Cancer stem cells; 
Multidrug-resistant bacteria, Pathogenic fungi, Influenza A virus; Cyclo(Phe-Pro) 
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1. 1. General introduction of lactic acid bacteria and cyclic dipeptides 
Lactic acid bacteria (LAB) are types of microorganisms that produce lactic acid as 
the primary and major metabolite when metabolizing sugar. Several type of LAB are 
widely known as probiotics since they are benefit for host animal by improving its 
intestinal microbial balance (Salminen et al. 1998). Actually, this group of probiotic 
bacteria are highly selected strains, including Lactobacillus spp., Bifidobacterium spp. 
Streptococcus spp. et al, which are capable of surviving in animal stomach (Conway et 
al. 1987) and defining gut survival properties and associated biological activates and 
which can be ingested in fermented milk products or as a supplement (Rafter 2002). 
Indeed, the probiotic effective of these kinds of strains are still accumulating and have 
been well reviewed (Salminen et al. 1998, Naidu et al. 1999, Masood et al. 2011). Beside 
their benefit for the nutrition and bowel activity, various disease prevention function of 
these probiotic strains were illustrated, especially relate to specific diseases, such as 
diarrhea (Chouraqui et al. 2004), lactose intolerance symptoms (Gorbach 1990), 
constipation (An et al. 2010), inflammatory bowel disease (del Carmen et al. 2010) as 
well as cancers (Adachi 1992, Hirayama and Rafter 2000, Rafter 2002). 
Among the broad spectrum of probiotic activity of LAB, the antimicrobial activities 
were under intensive studies. LAB have been considered to have antagonistic effects, 
such as inhibition of adherence, establishment, replication and various pathogenic 
actions in intestinal and food-borne pathogens in bench studies (De Vuyst and 
Vandamme 1994). In many types of naturally fermented foods, which originate from 
animals and plants (Lindgren and Dobrogosz 1990, Holzapfel et al. 2001). Studies have 
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shown the fermented mixture containing Lb. acidophilus is inhibitory to Shigella 
dysenteriae, Salmonella typhimurium, and Escherichia coli (Rani and Khetarpaul 1998) 
and inoculation of Lb. reuteri could suppresse Cryptosporidium parvum infection in 
C57BL/6 female mice (Alak et al. 1997). Lactococcus lactis, Streptococcus cremoris R3, 
Lactococcus diacetylactis V1and S. thermophilus T2 strains showed wide inhibitory 
spectra against the Gram-positive bacteria (Mezaini et al. 2009). For the antifungal 
ability, Lb. acidophilus, Lb. acidophilus reuteri, Lb. casei GG, and Bifidobacterium 
animalis were investigated by protecting athymic and euthymic mice from systemic 
candidiasis (Wagner et al. 1997, Gerez et al. 2009). Lb. coryniformis, Lb. plantarum and 
Pediococcus pentosaceus were also active against pathogenic fungi (Magnusson et al. 
2003, Valerio et al. 2009). In this study we isolate a strain of LAB with strong antibiotic 
activity. 
Most of the studies declared LAB can pass through the GI track alive and adherent 
to intestine wall. This alive adherent cells on intestine wall execute their probiotic active 
effect by secreting functional compounds during their proliferation. However, there are 
studies on antimicrobial indicated that these effective compounent may be found in 
culture filtrates (CFs) and these CFs may contribute for the benefit of human health. 
LAB generate abundance metabolites that induce a broad range of influence on their 
host or themselves. For example, organic acids produce by LAB are responsible for the 
decrease in the pH, under anaerobic conditions, hydrogen peroxide induce the 
environmental redox potential (Ricke 2003). Antimicrobial small molecules, as 
secondary metabolites of LAB, have been investigated in relation to cellular metabolism 
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during cell growth or fermentation, such as, bacteriocin-like peptide, organic acid, cyclic 
dipeptides (CDPs) and other small chemical molecules (Niku‐Paavola et al. 1999, 
Gänzle et al. 2000, Ström et al. 2002). Indeed, bacteriocin-like peptides, including 
bacteriocin, plantaricin and pediocin, have been demonstrated to be against Gram-
positive and Gram-negative bacteria (Biswas et al. 1991, Abee et al. 1995) and short 
chain fatty acids inhibit microbe growth. Most importantly, Furthermore, cis-cyclo(L-
Leu- L -Pro), cis-cyclo(L-Phe-L-Pro) and cis-cyclo(L-Val-L-Pro) were observed to be 
the most potent antiviral and antifungal CDPs from Lb. plantarum isolates (Gänzle et al. 
2000). We have proved LBP-K10 CF contains at least of one functional cyclic dipeptide 
with antibiotic activities. 
Cyclic dipeptides which consist of several kinds of diketopiperazines such as 2, 3-, 
2, 5- and 2, 6-isomers (Kwak et al. 2013, Kwak et al. 2014), have been suggested to 
have broad range of biological effects. They may function as quorum sensing signal 
molecules through reducing virulence factor production and cross talk with other 
bacterial strains as well as various antibiotic functions (Holden et al. 1999, Campbell et 
al. 2009, Li et al. 2011). Cyclo(Phe-Phe) inhibited the serotonin transporter and 
acetylcholinesterase as a dual inhibitor in vitro, preventing the development of 
Alzheimer's disease and dementia (Tsuruoka et al. 2012). Indeed, cyclic dipeptides 
participate in many cellular signaling pathways, such as Cyclo(Arg-Pro) as chitinase 
inhibitor CI-4 from a marine Pseudomonas sp. IZ208 (Izumida et al. 1996), and 
cyclo(dehydroAla-Leu) as α-Glucosidase inhibitor from Penicillium sp. F70614 were 
identified, respectively (Kwon et al. 2000). Cyclo(Phe-Pro) and cyclo(Tyr-Pro) from Lb. 
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reuteri were identified as signaling effectors in quorum sensing by attenuating virulence 
factor produced by staphylococci (Li et al. 2011). Interestingly, anti-hyperglycemic 
activity of zinc plus cyclo(His-Pro) suggested that oral intake of an optimal usage of 
cyclic dipeptides could control blood glucose concentrations by stimulating muscle 
glucose consumption in rats (Song et al. 2003). Recently, it was demonstrated that in 
vitro assessment regarding the probiotic and functional potential of Lactobacillus strains 
displayed the antagonistic activity against several types of pathogens along with the 
depletion of cholesterol and nitrate, free radical scavenging, immune response 
stimulation and highly production of exopolysaccharides (Ren et al. 2014). Additionally, 
Lactococcus spp., and Pediococcus spp. strains isolated Kefir also have a metabolic 
activity significantly similar to Lactobacillus spp. when observing the potential of 
probiotic properties (Sabir et al. 2010). In this study, we focused on these CDPs 
compounds generated by LAB. 
 
1. 2. Discovering antimicrobial CDPs in LAB 
The secondary metabolites produced by LAB have been investigated for small 
compounds with antimicrobial activity (Naidu et al. 1999, Rouse and van Sinderen 
2008). Of the different LAB strains, Lactobacillus spp. are known to produce low 
molecular weight antibiotic substances during metabolic processes (Messens and De 
Vuyst 2002) Among antibiotic small compounds from LAB culture filtrates, various 
different types of CDPs, which consist of several kinds of diketopiperazines such as 2, 
3-, 2, 5- and 2, 6-isomers (Kwak et al. 2013, Kwak et al. 2014), Considering the 
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antimicrobial compounds from Lactobacillus CFs, different types of cyclic dipeptides 
(CDPs), which consist of several kinds of diketopiperazines, including the 2, 3-, 2, 5- 
and 2, 6-diketopiperazines, have been widely investigated due to the potent antimicrobial 
functions against Gram-positive, Gram-negative bacteria and fungi (Witiak and Wei 
1990, Prasad 1995, Dinsmore and Beshore 2002). 
This diketopiperazines-ring system is formed through the condensation of two amino 
acids resulting in the smallest possible cyclic peptide (Eguchi and Kakuta 1974, Prasad 
1995, Bettens et al. 2000). 
Cyclic dipeptides have received an increasing attention since the first report in 1924 
(Abderhalden and Komm 1924), because of their diverse and bioactive activities, such 
as antitumor (Kanoh et al. 1999, Kanzaki et al. 2000), antiviral (Sinha et al. 2004) , 
antifungal (Asano 2003) (Houston et al. 2004), antibacterial (Sugie et al. 2001, Fdhila 
et al. 2003), antiprion, antihyperglycemic or glycosidase inhibitor activities as well 
reviewed by P De Carvalho, M. etc. (P de Carvalho and Abraham 2012). Cyclo(Trp-Trp) 
from Streptomyces sp. KH29 showed significant inhibitory activity against multidrug-
resistant Acinetobacter baumannii and also other bacterial and fungal strains (Lee et al. 
2010). 
Antibacterial synergistic activity of cyclo(Phe-Pro) and cyclo(Leu-Pro) from 
Streptomyces species has been reported against bacteria, even vancomycin-resistant 
Enterococcus faecium, Candida albicans and Cryptococcus neoformans (Rhee 2004). 
 Cyclo(Pro-Trp), cyclo(Phe-Pro), cyclo(Trp-Pro), cyclo(Trp-Trp), and histidine-
containing cyclic dipeptides were inhibitory to fungal strains such as C. albicans, 
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Aspergillus niger and Penicillium notatum (Graz et al. 1999, McCleland et al. 2004). 
Cyclo(Phe-Pro) and cyclo(Ile-Pro) from cell-free filtrates from propionibacteria also 
showed an antifungal activity against As. fumigatus and Rhodotorula mucilaginosa 
(Lind et al. 2007). Cyclo(Leu-Pro) and cyclo(Phe-Pro) from Lb. plantarum FST 1.7, 
Streptomyces sp. KH-614, Achromobacter xylosoxidans, and Lb. plantarum Mi. Lactic 
acid bacteria 393 have been responsible for antimicrobial activity against bacteria and 
fungi (Ström et al. 2002, Yan et al. 2004, Dal Bello et al. 2007). 
Recently, we also demonstrated the bioactivity of cis-cyclo(L-Leu-L-Pro) and cis-
cyclo(L-Phe- L-Pro) against influenza A virus (Kwak et al. 2013), along with cis-
cyclo(L-Val-L-Pro) and cis-cyclo(L-Phe-L-Pro) inhibitory to the growth of plant and 
human pathogenic Ganoderma boninense and C. albicans, respectively (Kwak et al. 
2014). In this study, we for the first time identified the entire compounds of CDPs pool 
in MC extracted fraction produce by Lb. plantarum LBP-K10 and confirmed their 
antibiotic effect. 
 
1. 3. Cancer prevention effect of LAB and its metabolic CDPs 
As mentioned above, the cancer prevention effect of CDPs has been discovered. 
Glycine-containing cyclic dipeptides, cyclo(Phe-Cys), and especially cyclo(Tyr-Cys) 
significantly inhibited cancer cell growth in HT-29, HeLa, and MCF-7 cells in vitro (Van 
der Merwe et al. 2008). Moreover, synthetic CDPs, such as cyclo(His–Phe) and 
cyclo(His-Tyr), have been reported to modify cellular ion channels, thereby inducing 
cell death in HeLa (cervical), WHCO3 (oesophageal) and MCF-7 (breast) carcinoma 
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cell lines and inhibiting the proliferation of bacteria and fungi (McCleland et al. 2004, 
Yan et al. 2004). Previously, we also successfully separated and purified a group of small 
molecules from a special strain of Lb. plantarum LBP-K10, with significant anti-
microorganism effect. These small molecules, named cyclic dipeptides (CDPs), are 
consist of several kinds of diketopiperazines such as 2, 3.-, 2, 5 and 2, 6-isomers (Kwak 
et al. 2013, Kwak et al. 2014). Including our studies, the existence of CDPs in LAB 
culture supernatant have been widely confirmed (Li et al. 2011, Perzborn et al. 2013). 
Besides the anti-microorganism activity, the tumor prevention effects of CDPs are also 
described. CDPs are found capable of inducing cancer cell apoptosis (Brauns et al. 2004, 
Brauns et al. 2005) or preventing gene mutation (Rhee 2004). 
However, most of anticancer studies are focused on gastrointestinal cancer cells, 
mainly on colon cancer and executed in vitro cell lines. Since the anti-cancer effect of 
CDPs was well demonstrated as above and studies confirmed the rapid absorption of 
CDPs in animal (Mizuma et al. 1998), we were encouraged to investigate of the cancer 
prevention effect of the specific LAB stain, Lb. plantarum LBP-K10, recent isolated in 
our team, which generating serial functional CDPs, on non-gastrointestinal cancer model. 
In this study, we discovered that oral in taking heat inactive cell-free of Lb. plantarum 
LBP-K10 (CF-K10) might effectively prohibit the progression in situ breast cancer 
progression in mouse transplantation model possibly through apoptosis pathways 
induced by CDPs. 
 
1. 4. Cyclic dipeptides synthesis and cyclic dipeptide synthetase 
9 
Since CDPs have these remarkable effect on anti-microorganism and even on cancer 
prevention, synthesis of this kind of molecules were intensively studied. Studies on the 
cyclic dipeptides have been focused on structures and synthetic methods related to their 
antimicrobial functions (Prasad 1995, O'Neill and Blackwell 2007, Trabocchi et al. 
2008, Budesinsky et al. 2010). The molecular scaffolds in cyclic dipeptides have been 
recognized as a privileged structural in the search for synthetic or semisynthetic 
pharmacological compounds (Prasad 1995, Izumida et al. 1996). Synthetic cyclic 
dipeptides such as cyclo(His–Phe) and cyclo(His-Tyr) were reported to modify cellular 
ion channels, thereby induce cell death in HeLa (cervical), WHCO3 (oesophageal) and 
MCF-7 breast carcinoma cell lines and furthermore inhibit proliferation of bacteria and 
fungi (Menard et al. 2004). And also, an albonoursin-producing strain, Streptomyces 
albulus KO-23 was reported to catalyze the conversion of cyclic dipeptides into the 
corresponding dehydro derivatives, which were observed to interfere with cell division 
(Kanzaki et al. 2000). A large number of diketopiperazines natural products could be 
obtained by chemical synthesizing route (Witiak and Wei 1990, Dinsmore and Beshore 
2002), which, however, generally are inefficiency and high-cost. 
Besides the chemical synthesizing route (Delaforge et al. 2001, Horton et al. 2002, 
Wang et al. 2002), cyclic dipeptides have been isolated from microbial sources or 
various foods. These evidences indicated the existance of biosynthesis route for cyclic 
dipeptide molecules (Jayatilake et al. 1996, Magnusson et al. 2003, Schnürer and 
Magnusson 2005). It has long been known that nonribosomal peptide synthetases are 
able to generate diketopiperazines-containing compounds, either through a dedicated 
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pathway or through the premature release of peptidyl intermediates via cyclization (Dal 
Bello et al. 2007, Giessen et al. 2013). The discovery of the albonoursin biosynthetic 
gene cluster in Streptomyces noursei and the characterization of the first cyclic dipeptide 
synthase AlbC (Belin et al. 2012, Li 2012), make it possible to form two successive 
peptide bonds in an ATP-independent fashion by hijacking aminoacyl-tRNAs from the 
ribosomal machinery (Belin et al. 2012). The Mycobacterium tuberculosis CDPS was 
found to generate cyclodityrosine through the formation of an aminoacyl-enzyme 
intermediate using aminoacyl-tRNAs as substrates (Bonnefond et al. 2011). Actually, 
cyclic dipeptides can directly using aa-tRNAs as substrates for the generation of a 
diketopiperazines-ring system (Yan et al. 2004). However, the knowledge of cyclic 
dipeptide synthesis still limited until now. In this study, we identified a novel CDPS 
from LAB and for the first time confirmed it capable of catalyzing amino acid to produce 
CDPs molecules in vitro and vivo. 
 
1. 5. Contents of this study 
 
1. 5. 1. Profiling entire CDPs compounds in Lb. plantarum LBP-K10 
Although the intra- and extracellular functions and the bioactivity of single CDPs 
have been revealed steadily for decades, all of the components of the CDPs pool, which 
is naturally produced by LAB, regarding the bioactivity or bio-significance in a given 
LAB culture have not been clearly identified. Herein, eight types of CDPs and one non-
peptidyl antibiotic component were isolated by high-performance liquid 
chromatography (HPLC) and confirmed by gas chromatography-mass spectroscopy 
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(GC-MS). On the basis of our previous studies regarding the antimicrobial and antiviral 
functions of a single CDP (Kwak et al. 2013, Kwak et al. 2014), we herein propose a 
method for purifying a massive amount of the total pool of CDPs, designated K10-
CCDP, from Lb. plantarum LBP-K10 CFs. We tried to address the significant bioactivity 
of both single CDPs and K10-CCDP, which was obtained from culture filtrates after 
removing impurities including organic acids or sugars through anion exchange 
chromatography (AEC). Thus, we identified a set of CDPs with antibiotic activity from 
a specific LAB species and provide a strategy for characterising the total set of CDPs 
from LAB cultures for the first time. 
 
1. 5. 2. CDPs participated in cancer prevention effect of LAB on breast cancer 
Although many studies investigated the anticancer activities of LAB, its effect on 
non-GI tract cancer has been rarely studied. Since the absorption of CDPs was proved 
previously and the stability of its special chemical structure, we expect LAB are capable 
of inhibiting the growth of breast cancer. In this study, the cancer prevention effect of 
LAB were confirmed first on in situ breast cancer model in mice and further revealed 
LAB may induced apoptosis in breast cancer cell line MDA-MB-231. Moreover, the 
growth inhibition effect of MC-K10 and cyclo(Phe-Pro)on cancer stem cell were also 
observed. These results provided new insight for the probiotic active of LAB, and also 
contribute to develop new strategies for breast cancer privation. 
 
1. 5. 3. Identifying a novel CDPS in Lb. plantarum LBP-K10 
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It was interested in identifying the CDPS, which synthesized the functional cyclic 
dipeptides. In this study, CDPS-like function of a novel protein (gi311821850) were 
reported, then the bioactive cyclic dipeptides of production, which in Lb. plantarum 
LBP-K10 through cyclic dipeptides synthase dependent pathway, were confirmed by 
ninhydrin activity staining. And the in vitro cyclic dipeptides synthesis conditions, based 
on the newly found CDPS protein, was successfully developed. After transfected this 
gene into E. coli, the expression of several identifying L-Proline base cyclic dipeptides 
were increased. The production of cyclic dipeptides were confirmed by high 
performance liquid chromatography and confirmed by gas chromatography-mass 
spectroscopy. The synthesis of cyclic dipeptides could be observed by HPLC when 
CDPS was applied in vitro conditions. To confirm the peaks in high-performance liquid 
chromatography represented cyclic dipeptides, each compound according each peak 
were collected and subjected to gas chromatography-mass spectroscopy analysis. To 
better understand that the mechanism of cyclic dipeptide synthesis in molecular level, 
X-ray analysis of CDPS was performed. This study elaborated the mechanism of cyclic 
dipeptides synthesis in lactic acid bacteria, and provided an opportunity for producing 






 Identification of cyclic dipeptides produced by 




2. 1. Aims 
 Profiling of entire CDPs compounds in MC extract of CF-K10 
 Structure identifying of each CDPs compounds 
 Antibiotic effect of each CDPs in MC extract of CF-K10 
 Antibiotic effect of CDPs complex conditioned by Lb. plantarum LBP-K10  
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2. 2. Materials and methods 
 
2. 2.1. Strains 
All bacterial, fungal and viral strains were listed in Table 1. Lb. plantarum LBP-K10 
and other isolates from Korean fermented kimchi were identified by 16S rDNA 
sequencing method and were cultured in mMRS as previously reported (Kwak et al. 
2013). Serially diluted bacterial cells were plated and grown on mMRS for CFU (ml) 
enumeration during cell growth (Panagou et al. 2007). 
All experiments were performed by using each single compound or K10-CCDP, 
which correspond to three different sets of CDPs from the CFs without organic acids, 
without sugars, or without organic acids and sugars, respectively. 
Antibacterial activity against multidrug-resistant bacteria and reference strains was 
measured every 24 h after seed inoculation and dilution method was used to determine 
the minimum inhibitory concentration (MIC) of antimicrobial substances (Huys et al. 
2002, Paulo et al. 2010). 
G. boninense isolate (GMR3) and C. albicans were grown and maintained to 
evaluate antifungal activity as described previously (Kwak et al. 2014). 
A plaque assay for antiviral activity was performed using Madin-Darby canine 
kidney (MDCK) cells grown in complete DMEM, and influenza A(H3N2)virus for 
infection as proposed previously (Kwak et al. 2013)
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Table 1|Strains, primers, and plasmids used in this study 
Strain Types or strains Source or reference 
LAB strains   
Ln. kimchii LBP-B02 Original isolate from fermented mustard leaves and stems This study 
W. cibaria LBP-B06 Original isolate from fermented mustard leaves and stems 
This study 
Lb. sakei LBP-S01 Original isolate from fermented stonecrop This study 
Lb. plantarum/pentos LBP-S02 Original isolate from fermented stonecrop This study 
Lc. lactis LBP-S03 Original isolate from fermented stonecrop 
This study 
S. sciuri  LBP-S07 Original isolate from fermented stonecrop This study 
Ln mesenteroides LBP-K06 Original isolate from fermented Chinese cabbage This study 
Lb. plantarum LBP-K10 Original isolate from fermented Chinese cabbage 
Kwak et al., 2013 
Ln. citreum LBP-K11 Original isolate from fermented Chinese cabbage This study 
W. cibaria LBP-K15 Original isolate from fermented Chinese cabbage 
This study 








S. aureus 11471 
oxacillin-resistant S. aureus (ORSA) 11471, which is resistant to 
beta-lactam antibiotics, including penicillins (methicillin, 
dicloxacillin, nafcillin and oxacillin) and cephalosporins 
This study, KNIH a 
S. pneumoniae 14596 
Streptococcus pneumoniae 14596, which is resistant to penicillin, 
erythromycin, tetracycline and clindamycin 
This study, KNIH a 
Gram-negative bacteria 
  
S. typhimurium 12219 
Salmonella typhimurium 12219, which is resistant to ACSSuT 
(ampicillin, chloramphenicol, streptomycin, sulphonamides and 
tetracycline) 
This study, KNIH a 
Pathogenic fungi   
C. albicans SC5314 Wild type isolate 
Fonzi and Irwin, 
1993 




 This was supported by Korea National Institute of Health
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2. 2. 2. Culture filtrate fractionation 
The supernatant from three-day cultured Lb. plantarum LBP K-10 was collected as 
previously described (Kwak et al. 2013). To obtain each CDP or K10-CCDP, filtered 
samples were separated using a semi-preparative HPLC system (Agilent, USA) with a 
semi-preparative Hypersil ODS C18 reverse-phase column (9.4  250 mm, Agilent, 
USA) as proposed previously (Kwak et al. 2013). 
 
2. 2. 3. Mass analysis and X-ray crystallography 
To perform electron ionization (EI) and chemical ionization (CI) of each fraction, 
GC-MS (Agilent, Germany) was utilized (Kwak et al. 2013). A chromatographic system 
consisting of an Agilent 6890 series GC equipped with a 7679 series automatic liquid 
sampler was used. Mass analysis was conducted using a high-resolution mass 
spectrometer (JEOL JMS-700, Japan). 
Crystals of bioactive CDPs were coated with paratone-N oil, and the diffraction data 
were measured at 95 K with synchrotron radiation ( = 0.66999 Å) on an ADSC 
Quantum-210 detector with a silicon (111) double crystal monochromator (DCM) at the 
2D SMC beamline at Pohang Accelerator Laboratory, Korea (Kwak et al. 2013). These 
crystal structures were deposited at the Cambridge Crystallographic Data Centre 
(https://www.ccdc.cam.ac.uk/services/structure_deposit/). 
 
2. 2. 4. K10-CCDP preparation 
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K10-CCDP was prepared from CFs using both primary AECs and a secondary 
immediate compound-refinement process. The secondary refinement procedure included 
the following three sequential steps: MC extraction of the eluents from the primary 
AECs, HPLC fractionation/collection only from F1 to F17 of this MC extract, and finally 
repetition of the MC extraction on each of the collected fractions. 
Basically, we tried to remove organic acids and sugars from the CFs via three sets 
of AECs. To eliminate impurity-based side reactions and interference from organic acids 
or sugars, the resins Amberlite IRA-67 (Sigma-Aldrich, USA) and Purolite A420S 
(Purolite, USA) were selected as the weakly or strongly basic anion exchangers, 
respectively, with modifications (Maciel de Mancilha and Karim 2003, Moldes et al. 
2003, Roja et al. 2005). Before the AEC was used to recover organic acids and sugars, 
Amberlite IRA-67 and Purolite A420S were converted into the free base OH or Cl 
forms, respectively. The CF was applied to Amberlite IRA-67 resin-packed open 
columns at a flow rate of 15 ml/min, and the unbound eluent was collected. Then, 
Purolite A420S was utilized to remove sugars from both the CFs and the organic acid-
removed primary eluents. Additionally, the refining process was performed by extraction 
of the AEC eluents with 10-fold volumes of MC for further HPLC fractionation. To 
avoid collecting impurities, such as compounds that competitively bind to a C18 column 
during HPLC, the filtered samples were re-separated, and only seventeen fractions were 
collected. The resulting samples were again lyophilized, extracted with MC and filtered 
for antibiotic assays. Three types of K10-CCDP were prepared in this way and were 
designated according to the type of AEC that was used: K10-CCDP-I (CF without 
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organic acids), K10-CCDP-II (CF without sugars) and K10-CCDP-III (CF without 
organic acids and sugars) (Fig. 1). 
 
2. 2. 5. Statistical analysis 
The results are presented as the means ± standard deviation (SD). The statistical 
significance of the differences was tested using Student’s t-test in Microsoft Office Excel 




Fig. 1. Three types of K10-CCDP was prepared using various types of column 
chromatography followed by MC extraction. All procedures for purifying K10-CCDP 
from the Lactobacillus CFs are shown. The corresponding chromatography using 
weakly or strongly basic anion exchange is indicated (arrow).  
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2. 3. Results 
 
2. 3. 1. Characterization of the potent antimicrobial isolate 
We isolated approximately 400 strains from three types of Korean traditional kimchi 
and 200 strains were identified as LAB with an antimicrobial activity among these 
isolates (Table 2). Of these bacterial CFs, thirty isolates with potent antibacterial activity 
were selected and herein Lb. plantarum LBP-K10 CF exhibited the most significant 
activity against reference strains (Table 3 and Fig. 2A). These results consistence to 
studies on the Lb. plantarum strains originated from different varieties of kimchi, which 
showed a higher antimicrobial activity compared to any other isolate (Lee et al. 2007, 
Lim and Im 2009, Yang et al. 2011). Moreover, Lb. plantarum WCFS1 was suggested 
to be capable of encoding pyruvate-dissipating potential and being known as a fermenter 
with superb nutritional and bioactive properties (Kleerebezem et al. 2003). It was also 
demonstrated that in vitro assessment regarding the probiotic and functional potential of 
Lactobacillus strains displayed the antagonistic activity against several types of 
pathogens along with other physiological functions including the depletion of cholesterol 
and nitrate, free radical scavenging, immune response stimulation and highly production 
of exopolysaccharides (Ren et al. 2014). Therefore, to optimize the experimental 
conditions for the purification of antimicrobial substances in the isolated Lb. plantarum 
LBP-K10 CF, we preferentially observed the cell growth associated with antibacterial 
activity as proposed (Nardi et al. 2005). Despite the increased optical density, the CFU 
significantly inversely decreased after 32 h (Fig. 2B), at which time the pH 
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concomitantly decreased approximately 3.8 (Fig. 2C). This result indicates that changes 
in the CFU and pH values, which were both followed by the enhancement of antibacterial 
activity, might have been affected by metabolic by-products throughout the entire period 
(Fig. 2D). This preliminary evidence for the isolated bacterial CFs coincided with the 
bactericidal activity of CFs in the Lb. plantarum C-11, Lb. sake 706 and Lb. murinus 
strain L1 isolated from cucumber, meat and faeces of a Wistar rat, respectively 
(Schillinger and Lücke 1989, Nardi et al. 2005). Simultaneously, the amount of each 
fraction significantly increased during cell growth, which showed the time point with 
the highest total amount was 72 h (Fig. 2E). Based on these findings, we compared the 
production of antifungal and antiviral CDPs produced by Lb. plantarum LBP-K10 at 72 
h (Fig. 3A) with reference to previously identified several types of L-proline based CDPs 
(Kwak et al. 2013, Kwak et al. 2014). Interestingly, all fractions of the isolates showed 
an identical fractionation pattern, although the relative amount in the fractions of the Lb. 
plantarum LBP-K10 CF was significantly higher than that in any other isolate (Fig. 3A). 
The fractions of CF from P. pentosaceus, which have a low amount of fractions 
compared to Lb. plantarum LBP-K10 and Leuconostoc mesenteroides LBP-K06, was 
shown, along with mMRS broth as a reference experiment (Fig. 4). This result suggests 
that despite the differences in the amount of substances among the isolates, LAB might 
synthesize and similarly excrete analogous metabolites functioning as bioactive 
mediators including antifungal and antiviral CDPs (Kwak et al. 2013, Kwak et al. 2014). 
Moreover, to verify the principal CDPs produced in the LAB, the three-day cultured Lb. 
plantarum LBP-K10 was harvested and regrown in 25 mM sodium phosphate buffer (pH 
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7.4) in the presence or absence of D-glucose (Fig. 3B). The significant higher amounts 
of the CDPs ranging from F11 to F15 were produced by L-proline supplemented 
Lactobacillus cells, particularly in the presence of D-glucose although the glucose-
depleted buffer conditions did not cause a change in the growth rate (Fig. 3B). Based on 
the result of a significantly increased cis-cyclo(L-Leu-L-Pro) under all experimental 
conditions, this unique finding indicates that Lb. plantarum LBP-K10 might produce cis-
cyclo(L-Leu-L-Pro) predominantly prior to other metabolites (Fig. 3B). Thus, due to the 
CDP-rich CF of Lb. plantarum LBP-K10 bearing the most potent antibiotic properties, 
this strain was used to purify all of the single CDPs and K10-CCDP in this study.  
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Table 2 LAB strains isolated from traditional korean fermented plant materials 
 
Source and strain number 
Mustard leaves and 
stems 
Stonecrop Chinese cabbage 
Leuconostoc spp. 93 10 28 
Lactobacillus spp. 14 8 17 
Lactococcus spp. - 1 - 
Weissella spp. 2 14 18 
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LBP-B01   Lb. sakei 
LBP-B02   L. kimchii
LBP-B03   Ln. mesenteroides 
LBP-B04   Ln. mesenteroides 
LBP-B05   
Ln. 
paramesenteroides 
LBP-B06   W. cibaria
Stonecrop 
LBP-S01    Lb. sakei 
LBP-S02   Lb. plantarum/pentos
LBP-S03   Lc. lactis
LBP-S04   L. citreum
LBP-S05   L. citreum
LBP-S06   L. lactis
LBP-S08   W. hellenica
Chinese cabbage 
LBP-K01   Lb. plantarum 
LBP-K03   L. citreum
LBP-K04   L. citreum
LBP-K05   L. holzapfelii
LBP-K06   Ln. mesenteroides
LBP-K07   
Ln.
pseudomesenteroides
LBP-K08   Ln. mesenteroides
LBP-K09   Lb. brevis
LBP-K10   Lb. plantarum
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LBP-K11   Ln. citreum 
LBP-K12   Ln. mesenteroides 
LBP-K13   Ln. mesenteroides 
LBP-K14   
Ln. 
pseudomesenteroides 
LBP-K15   W. cibaria 
LBP-K16   W. confusa 
a Symbol: +, <15 mm; ++, <22 mm; +++, >22 mm (Indicator strain: B. subtilis) 
b MIC: Minimum inhibitory concentration 
c Symbol: +, 1-fold; ++, 0.5-fold; +++, less than 0.25-fold (Indicator strain: B. subtilis) 




Fig. 2. The highest level of antimicrobial activity of Lb. plantarum LBP-K10 CF. 
(A) A comparison of the antibacterial activity of the following isolated lactic acid 
bacteria: (1) Weissella cibaria LBP-B06, (2) Lb. sakei LBP-S01, (3) Ln. kimchi LBP-
B02, (4) Lb. plantarum LBP-K10, (5) Ln. citreum LBP-K11, and (6) Ln mesenteroides 
LBP-K06. Disc diffusion assays were performed using B. subtilis (left) and E. coli 
(right). (B) Cell growth, as indicated by the absorbance at 600 nm, and the corresponding 
cell viability as determined by counting the cell colony numbers (CFU ml1). (C) 
Decrease in pH during the growth of Lb. plantarum LBP-K10. (D) Antibacterial activity 
and pH of the Lb. plantarum LBP-K10 CF. (E) A significant increase in the antimicrobial 
and antiviral CDPs produced by Lb. plantarum LBP-K10 with respect to incubation 
time. The measured data values are representative of the average ( standard deviation) 






Fig. 3. The production of a large amount of CDPs by Lb. plantarum LBP-K10 
compared with various tested isolates. 
(A) HPLC profiles of Lb. plantarum LBP-K10 and the following other isolated lactic 
acid bacteria: Lb. sakei LBP-S01, Lb.plantarum/pentos LBP-S02, Lb.LBP-S03, Lb. 
lactis LBP-S06, Staphylococcus sciuri LBP-S07, Ln. mesenteroides LBP-K06, Lb. 
plantarum LBP-K10, W. cibaria LBP-K15 and Weissella confusa LBP-K16. A 
chromatographic analysis of Lb. plantarum LBP-K10 was performed every 8 h with 
detection at 210 nm. The predominant production of cis-cyclo(L-Leu-L-Pro) by Lb. 
plantarum LBP-K10 under several conditions. (A) Changes in HPLC profiles of cis-
cyclo(L-Leu-L-Pro). Lactobacillus cells were grown as described in the Experimental 
procedures after supplementation with 2.0 mM L-proline in mMRS. The filtrate from a 
three-day culture of Lb. plantarum LBP K-10 was extracted using methylene chloride 
for chromatographic analysis. (B) Changes in the biosynthesis of cis-cyclo(L-Leu-L-
Pro). All grown Lactobacillus cells were harvested and washed twice. All experiments 
were performed in 25 mM sodium phosphate (Na2HPO4) buffer at a pH of 7.2, with or 




Fig. 4. HPLC fractionation pattern of the CFs in isolated lactic acid bacteria. A 
chromatographic analysis of the CFs driven by LAB strains was performed at 72 h with 




2. 3. 2. Seventeen fractions from the CF contain sixteen CDPs 
From three-day cultured Lb. plantarum LBP-K10 filtrate containing bioactive CDPs, 
seventeen fractions were isolated and characterized by GC-MS analysis or X-ray 
crystallography (Fig. 5). The fragmentation patterns in the EI-MS spectra of a series of 
corresponding fractions were completely identical to the CDPs that were characterized 
from various sources of food materials as proposed previously (Stark and Hofmann 
2005, Wang et al. 2010). Surprisingly, the EI and CI values corresponding to all fractions 
were observed to be entire CDPs except for one fraction, including seven types of 
proline-based CDPs, one type of non-proline-based cyclo(Phe-Ala) and non-peptidyl 
DL-3-phenyllactic acid, respectively (Figs. 6, 7 and Table 4). Additionally, we 
previously reported several types of cis-configured diketopiperazines (Kwak et al. 2013, 
Kwak et al. 2014), partly including F7, F8, F13 and F17, and DL-3-phenyllactic acid. 
The crystal structures of active fractions have been assigned to the following deposition 
numbers: F7 (cis-cyclo(L-Val-L-Pro)-CCDC 937497) (Kwak et al. 2014); F8 (cis-
cyclo(L-Leu-L-Hyp)-CCDC 937498); F13 (cis-cyclo(L-Leu-L-Pro)-CCDC 937533) 
(Kwak et al. 2013); F15 (DL-3-phenyllactic acid- CCDC 951328); and F17 (cis-cyclo(L-
Phe-L-Pro)-CCDC 937534) (Kwak et al. 2013).
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56.1 (28.9), 61.2 (12.2), 70.2 (80.1), 76.2 (16.2), 85.2 (100.0), 86.2 (31.9), 
91.2 (84.2), 98.2 (16.1), 99.2 (7.8), 111.3 (38.7), 128.3 (45.5), 141.3 (8.8), 
148.3 (21.3), 154.3 (45.9), 155.3 (10.5), 170.4 (35.3), 184.4 (11.3), 196.4 






55.1 (18.7), 69.2 (30.2), 70.2 (44.4), 74.2 (2.6), 83.2 (52.7), 98.2 (20.4), 







55.2 (17.8), 69.3 (28.6), 70.3 (68.3), 83.3 (41.7), 86.3 (10.6), 98.3 (17.0), 
111.3 (57.3), 114.3 (3.7), 126.4 (9.1), 140.4 (2.3), 154.4 (100), 155.4 (10.9), 







55.2 (14.2), 58.2 (4.6), 68.2 (14.8), 69.2 (37.6), 70.3 (100), 71.3 (20.6), 83.3 
(7.7), 86.3 (10.1), 97.3 (58.6), 98.3 (10.7), 111.3 (9.4), 112.3 (8.4), 114.3 
(21.3), 125.4 (34.1), 126.3 (33.4), 140.4 (10.2), 154.4 (31.0), 168.5 (63.9), 









54.9 (14.2), 56.0 (13.5), 68.0 (14.1), 69.0 (25.2), 70.0 (100.0), 71.0 (10.3), 
83.9 (17.6), 84.9 (13.6), 85.9 (10.0), 95.9 (10.3), 96.9 (21.7), 97.9 (8.2), 
106.9 (28.7), 111.9 (23.9), 113.9 (39.3), 124.9 (21.3), 125.9 (9.9), 139.9 
(7.6), 140.9 (4.2), 153.9 (10.5), 154.9 (2.0), 155.9 (4.6), 167.9 (45.3), 168.9 







261.2 (2.3), 260.2 (12.4), 244.2 (1.2), 224.2 (1.2), 155.1 (8.7), 154.1 (100.0), 
153.1 (3.7), 147.1 (1.2), 125.1 (4.1), 114.1 (0.2), 108.1 (4.6), 107.1 (38.7), 
91.1 (2.1), 77.1 (3.3), 71.1 (1.4), 70.1 (18.8) 
cyclo(Tyr-Pro), 
C14H16N2O3  





196.2 (9.2), 181.1 (1.9), 169.1 (0.4), 168.1 (0.7), 167.1 (0.8), 156.1 (1.4), 
155.1 (16.3), 154.0 (100.0), 153.1 (14.3), 152.1 (2.1), 140.1 (2.3), 139.1 
(1.1), 138.1 (6.2), 137.1 (2.1), 125.1 (44.8), 114.1 (3.2), 113.1 (1.1), 112.1 
(1.8), 111.1 (1.0), 110.1 (5.3), 107.1 (2.0), 100.1 (0.3), 99.1 (3.2), 98.1 (8.0), 
97.1 (3.3), 96.1 (2.4), 84.1 (2.8), 83.1 (2.3), 82.1 (1.8), 76.1 (3.5), 73.1 (5.2), 
72.1 (48.0), 71.1 (7.1), 70.1 (86.7), 69.1 (15.2), 68.1 (8.4) 
cis-cyclo(L-Val-L-
Pro), C10H16N2O2  





227.9 (5.1), 213.0 (1.26), 181.0 (7.60), 166.9 (3.2), 154.0 (11.8), 91.0(8.1), 








154.0 (3.3), 149.0 (5.2), 141.0 (7.9), 129.0 (9.8), 128.0 (100.0), 127.0 (3.3), 
113.0 (20.3), 112.0 (4.2), 99.0 (8.0), 98.0 (4.7), 92.0 (3.7), 91.0 (6.2), 86.0 
(15.0), 85.0 (6.4), 84.0 (5.7), 83.0 (3.4), 71.1 (7.0), 70.1 (10.4), 69.0 (7.8), 
60.0 (3.8), 57.0 (13.2), 56.0 (6.0), 55.0 (7.4) 
cyclo(Ser-Pro), 
C8H12N2O3  







217.9 (12.6), 182.0 (3.0), 168.9 (5.4), 154.0 (77.1), 141.0 (8.1), 128.0 (41.2), 
125.9 (24.5), 125.0 (13.9), 122.0 (11.4), 120.9 (12.6), 100.0 (17.2), 99.0 
(13.5), 98.0 (12.0), 97.0 (8.2), 91.0 (34.4), 87.0 (37.1), 86.0 (17.8), 76.0 








260.1 (12.9), 244.1 (21.6), 169.1 (9.3), 168.1 (8.7), 167.1 (6.8), 155.1 (11.1), 
154.1 (100.0), 153.1 (20.7), 152.1 (4.1), 141.1 (9.8), 125.1 (30.0), 120.1 
(10.0), 114.0 (10.8), 111.1 (25.8), 107.1 (19.7), 98.1 (10.8), 97.1 (11.1), 92.1 
(7.8), 91.1 (38.7), 86.1 (17.1), 85.1 (12.5), 84.0 (24.3), 83.1 (22.9), 82.1 
(5.8), 81.1 (7.3), 77.0 (8.1), 74.0 (7.8), 73.0 (6.3), 72.1 (6.7), 71.1 (11.7), 
70.1 (61.9), 69.1 (22.9), 68.0 (14.4), 67.1 (6.1), 65.0 (5.7), 60.0 (7.2), 57.1 








210.0 (0.5), 195.0 (0.6), 181.0(1.2), 168.0 (0.6), 167.0 (2.0), 156.0 (0.8), 
155.0 (8.8), 154 (100.0), 153.0 (5.3), 125.0 (11.9), 98.0 (2.8), 86.0 (18.2), 
70.0 (48.5), 55.0 (3.3) 
cyclo(Leu-Pro), 
C11H18N2O2  





166.1 (10.7), 154.1 (33.9), 148.0 (30.4), 135.1 (11.4), 125.1(3.0), 121.1 
(12.2), 105.0 (19.0), 103.1 (13.2), 91.0 (100.0), 87.1 (66.0), 77.1 (13.5), 76.0 
(40.2), 75.1 (22.5), 71.1 (7.7), 70.1 (20.9), 69.1 (76.2), 65.1 (12.1), 57.1 
(20.7), 55.0 (7.0), 51.0 (6.4) 
cis-cyclo(L-Leu-L-
Pro), C11H18N2O2  





166.1 (10.7), 154.1 (33.9), 148.0 (30.4), 135.1 (11.4), 125.1(3.0), 121.1 
(12.2), 105.0 (19.0), 103.1 (13.2), 91.0 (100.0), 87.1 (66.0), 77.1 (13.5), 76.0 
(40.2), 75.1 (22.5), 71.1 (7.7), 70.1 (20.9), 69.1 (76.2), 65.1 (12.1), 57.1 










168.1 (0.3), 167.1 (1.9), 166.1 (13.6), 154.1 (5.4), 149.1 (7.5), 148.1 (58.6), 
147.1 (10.4), 130.1 (2.6), 129.1 (1.9), 122.1 (2.1), 121.1 (15.9), 120.1 (4.2), 
104.1 (2.9), 103.1 (22.9), 102.1 (1.7), 93.1 (2.3), 92.1 (27.2), 91.1 (100), 79.1 

















245.0 244.1 (97.5), 153.0 (82.0), 125.1 (100.0), 91.0 (52.3), 70.1 (46.3) 
cis-cyclo(L-Phe-L-
Pro), C14H16N2O2  
(Kwak et al., 2013; 
Kwak et al., 2014) 




Fig. 5. Overall profiles of purified substances from Lb. plantarum LBP-K10 CFs. All fractions were identified as low 








Fig. 6. Structural analysis of seventeen fractions from Lb. plantarum LBP-K10. (A)-
(Q) corresponding to F1-F17 obtained by GC-MS-EI/CI. The EI and CI values of each 
fraction were measured. From these fractions, the mass spectra of the following 
antibacterial, antifungal and antiviral substances are also shown: (A) F1, cyclo(Tyr-Pro); 
(B) F2 cyclo(Ser-Pro); (C) F3, cyclo(Leu-Pro); (D) F4, cyclo(Leu-Pro); (E) F5, 
cyclo(Val-Pro); (F) F6, cyclo(Tyr-Pro); (G) F7, cis-cyclo(L-Val-L-Pro); (H) F8, cis-
cyclo(L-Leu-L-Hyp); (I) F9, cyclo(Ser-Pro); (J) F10, cyclo(Phe-Ala); (K) F11, 
cyclo(Tyr-Pro); (L) F12, cyclo(Leu-Pro); (M) F13, cis-cyclo(L-Leu-L-Pro); (N) F14, 





Fig. 7. The identified CDPs from F1 to F17 are summarised. The EI fragmentation 
patterns are shown as indicated. Structural units separated by chemical bonds are divided 
by dashed lines. 
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2. 3. 3. Antimicrobial activity of seventeen fractions
Due to the possible relevance to the conformational variation-related differences of
bioactivity, we presumably hypothesized that the difference in the activity of different 
fractions that contain the same antimicrobial CDP might be caused by several types of 
diastereoselective or enantiomeric structures of CDPs as described. In the case of the 
synthesized CDPs, they could be interconverted by different diastereoselective or 
enantiomeric fashion influenced by pH, acylation and alkylation of chiral enolates 
(Borthwick 2012). It was also proven that a significant antibacterial activity of cyclo(D-
Trp-D-Arg) contrast to a lower activity in the cyclo(L-Trp-L-Arg) might be due to the 
difference in the chirality properties of the tryptophan and arginine, which could form 
different spatial orientation that function as a crucial role in the enhancement of 
biological activities (Deepa et al. 2015). As predicted by stereochemistry that can play a 
pivotal role in the bioactivity of CDPs (Houston et al. 2004), a broad spectrum of 
antibacterial activity was commonly observed in the fractions containing proline based 
diketopiperazines, including F1, F3, F4, F6, F7, F8, F11, F12, F13 and F17 (Table 5). 
This antibacterial property driven by some types of CDPs corresponded to previous 
investigations particularly when using proline based cyclo(Leu-Pro) and cyclo(Phe-Pro) 
from Lactobacillus isolates, Streptomyces sp. KH-614 and Ac. xylosoxidans, 
respectively (Ström et al. 2002). Additionally, cyclo(Phe-Pro) and cyclo(Ile-Pro) from 
Propionibacterium CF showed antifungal activity against As. fumigatus and R. 
mucilaginosa (Lind et al. 2007). This observation also coincided with our previous 
investigations regarding the increased amount of poline-based fractions against microbes 
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(Kwak et al. 2013, Kwak et al. 2014), including cyclo(Tyr-Pro) (F6), cis-cyclo(L-Val-
L-Pro) (F7), cyclo(Ser-Pro) (F9), cyclo(Leu-Pro) (F12), cis-cyclo(L-Leu-L-Pro) (F13) 
and cis-cyclo(L-Phe-L-Pro) (F17) (Fig. 3 and Fig. 2E). Therefore, all of the single CDPs 
potently inhibitory to bacteria, fungi and virus were summarized (Table 6), suggesting 
that the significant antibacterial activity against multidrug-resistant bacteria was shown 
particularly when treating cis-cyclo(L-Leu-L-Pro) (F13) (Tables 5 and 7). This result 
also corresponded to previous report regarding the effect of cyclo(L-leucyl-L-prolyl) and 
cyclo(L-phenylalanyl-L-prolyl) on the growth of five vancomycin-resistant enterococci 
(VRE) strains and pathogenic yeasts. 
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Table 5 Relative antibacterial activity of each fraction isolated from CF of Lb. plantarum LBP-K10 
Strain F1 F2 F3 F4 F5 F6 F7 F8 F9 
1 Antagonism testa*          
1 Antagonism testb*          
2 MICc* 6.5  6.5 3.25  6.5 6.5 6.5  
2 MICd* 6.5  6.5 3.25  6.5 3.25 3.25 6.5 
F10 F11 F12 F13 F14 F15 F16 F17 
1 Antagonism testa*         
1 Antagonism testb*         
2 MICc*  6.5 3.25 1.63    6.5 
2 MICd*  6.5 3.25 1.63    3.25
1 Symbol: +, <15 mm; ++, <22 mm; +++, >22 mm (Indicator strains: B. subtilis a, E. coli b) 
2 MIC: Minimum inhibitory concentration (Indicator strains: B. subtilisc, E. coli d) 
* All experiments represent the average of three independent experiments.
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Table 6 Antibacterial, antifungal and antiviral activity of the isolated CDPs from Lb. plantarum LBP-K10 
Fraction m/z of [M+1]+ Molecule Activity Source or reference 
F1 260.0 cyclo(Tyr-Pro) antifungal This study 
F2 184.0 cyclo(Ser-Pro) antifungal This study 
F3 210.0 cyclo(Leu-Pro) antibacterial, antifungal and antiviral This study 
F4 210.0 cyclo(Leu-Pro) antibacterial, antifungal and antiviral This study 
F5 194.0 cyclo(Val-Pro) antifungal This study 
F6 260.0 cis-cyclo(L-Tyr-L-Pro) antifungal Kwak et al., 2014 
F7 196.0 cis-cyclo(L-Val-L-Pro) antifungal Kwak et al., 2014 
F8 226.0 cis-cyclo(L-Leu-L-Hyp) Antibacterial and antifungal This study 
F9 184.0 cis-cyclo(L-Ser-L-Pro) antifungal Kwak et al., 2014 
F10 218.0 cyclo(Phe-Ala)  This study 
F11 260.0 cyclo(Tyr-Pro) antifungal This study 
F12 210.0 cis-cyclo(L-Leu-L-Pro) antifungal Kwak et al., 2014 
F13 210.0 cis-cyclo(L-Leu-L-Pro) antibacterial, antifungal and antiviral 
Kwak et al., 2013,Kwak et al., 
2014 
F14 227.0 cyclo(Met-Pro)  This study 
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F15 166.0 DL-3-phenyllactic acid antifungal 
Ström et al., 2002, 
This study 
F16 244.0 cyclo(Phe-Pro) antibacterial, antifungal and antiviral This study 
F17 244.0 cis-cyclo(L-Phe-L-Pro) antibacterial, antifungal and antiviral 




Table 7 Antibacterial activity of cis-cyclo(L-Leu-L-Pro) produced by Lb. plantarum 
LBP-K10 
Indicator strains MIC (mg/l) a,* 
Gram-positive bacteria  
Bacillus subtilis 12.42 
Staphylococcus aureus 10.08 
Listeria monocytogens 10.29 
Streptococcus pneumoniae 9.81 
Gram-negative bacteria  
Salmonella typhimurium 12.08 
Escherichia coli 11.88 
Shigella dysenterii 10.45 
Multidrug-resistant strain  
Gram-positive bacteria  
Staphylococcus aureus 11471b 21.67 
Streptococcus pneumoniae 14596 b 21.25 
Gram-negative bacteria  
Salmonella typhimurium 12219 c 7.40 
a MIC: Minimum inhibitory concentration. 
b Multidrug-resistant Gram-positive bacteria. 
c Multidrug-resistant Gram-negative bacteria. 
* The values represent the average of three independent experiments.  
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2. 3. 4. K10-CCDP purification 
Previously, we performed plaque assays to measure the antiviral activity of organic 
acid removed-CFs (Kwak et al. 2013), which had been successfully performed by 
modifications through Amberlite IRA-67 resin to isolate CDPs from CF for the first time. 
Particularly, we collected the unbound eluent from AEC using Purolite A420S to remove 
sugars with modifications, independently of using Amberlite IRA-67. Because the 
sequential use of the two resins was able to separate CDPs and remove both organic 
acids and sugars, the resulting total amounts of lyophilized compounds could be 
calculated through the AEC applications followed by MC extraction (Table 8). 
Interestingly, the resulting HPLC chromatograms of these three primary extracts showed 
a similar pattern compared to CFs from the isolated LAB (Fig. 8). After the fractions had 
been collected by HPLC, only fractions F1 to F17 that were sequentially re-extracted 
with MC and also the resulting three types of secondary MC extracts were lyophilized 
and re-quantified (Tables 9 and 10). Considering all of the data, we found that organic 
acids and sugars were effectively eliminated by three sets of AEC applications and the 
resultant lyophilized powders were used as bioactive K10-CCDP.  
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Table 8 Amounts of substances after the primary purification of K10-CCDP using 
AEC 
Performance Total quantity (mg/l)a  
Culture filtrate without organic acids  
without methylene chloride extraction, a 28,097.5  33.4 
with methylene chloride extraction, b 497.5  9.89 
yield, % (b  a 100) 1.77 
Culture filtrate without sugars  
without methylene chloride extraction, c 27,457.6  22.4 
with methylene chloride extraction, d 350.2  5.92 
yield, % (d  c 100) 1.28 
Culture filtrate without organic acids and sugars  
without methylene chloride extraction, e 25,444.5  28.8 
with methylene chloride extraction, f 292.5  4.68 
yield, % (f  e 100) 1.15 
a The values represent the average of three independent experiments.
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Table 9 Total amounts of substances after the secondary purification of K10-CCDP by semi-prep HPLC followed by MC extraction 
Identified 
compound 
Total quantity in Lb. plantarum LBP-K10 
Culture filtrate K10-CCDP-I K10-CCDP-II K10-CCDP-III 
mg/la μM mg/la μM mg/la μM mg/la μM 
F1 8.240.21 31.670.81 16.660.61 64.02.35 14.292.81 54.8910.8 9.170.74 35.22.9 
F2 2.880.04 15.640.22 1.780.13 9.660.68 1.590.13 8.650.69 1.50.06 8.150.31 
F3 3.900.05 18.530.25 7.730.54 36.72.55 8.651.26 41.15.98 4.080.26 19.41.23 
F4 1.050.20 5.010.96 1.620.01 7.690.47 1.380.26 6.571.24 1.260.05 5.950.25 
F5 0.830.29 4.251.50 2.730.19 13.80.94 1.640.11 8.380.55 1.340.13 6.830.65 
F6 16.10.08 62.00.30 14.02.34 53.88.98 12.91.21 49.674.66 10.431.72 40.06.62 
F7 9.310.12 47.440.60 12.50.93 64.24.75 16.11.45 82.17.39 11.31.62 57.98.26 
F8 3.040.05 13.410.21 6.621.74 29.37.69 9..391.94 41.58.58 5.60.27 24.741.18 
F9 1.520.23 8.271.26 2.220.13 12.030.73 1.120.13 6.080.72 0.920.06 5.010.31 
F10 0.980.13 4.490.59 10.631.37 48.76.27 15.40.89 70.84.06 8.30.74 38.03.39 
F11 3.300.11 12.690.45 1.260.06 4.8440.23 0.410.03 1.570.13 0.860.15 3.20.57 
F12 4.320.14 20.50.67 2.690.03 12.70.12 2.670.01 12.70.05 2.380.17 11.30.82 
F13 3.280.38 15.601.83 1.510.005 7.170.02 1.530.003 7.290.02 1.430.01 6.80.04 
F14 2.090.05 9.150.24 0.920.07 4.010.3 1.140.03 5.030.14 0.850.39 3.711.72 
F15  2.340.07 14.070.4 1.630.02 9.820.11 2.780.04 16.70.22 1.440.11 8.690.66 
F16 1.680.08 6.870.32 1.740.23 7.110.97 0.190.01 0.770.05 0.120.02 0.480.07 
F17 7.140.23 29.210.96 17.640.08 72.10.31 2.010.32 8.211.29 1.960.34 8.011.41 
a The values represent the average of three independent experiment 
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Table 10 Summary of the total amounts of CDPs and DL-3-phenyllactic acid in K10-CCDP 
Identified compound 
Total quantity in Lb. plantarum LBP-K10 
Culture filtrate K10-CCDP-I K10-CCDP-II K10-CCDP-III 
mg/l μM mg/l μM mg/l μM mg/l μM 
cyclo(Leu-Pro) 12.6 60.1 13.5 64.4 14.2 67.7 9.14 43.4 
cyclo(Phe-Pro) 8.8 36.0 19.3 79.2 2.19 8.98 2.07 8.49 
cyclo(Tyr-Pro) 27.7 106.3 31.9 122.6 27.6 106.1 20.4 78.6 
cyclo(Ser-Pro) 4.4 23.9 3.99 21.6 2.71 14.73 2.42 13.1 
cyclo(Val-Pro) 10.1 51.6 15.3 78.0 17.7 90.4 12.7 64.7 
cis-cyclo(L-Leu-L-Hyp) 3.0 13.4 6.62 29.2 9.39 41.5 5.60 24.7 
cyclo(Phe-Ala) 0.98 4.49 10.6 48.6 15.4 70.8 8.30 38.0 
cyclo(Met-Pro) 2.09 9.15 0.92 4.01 1.15 5.03 0.85 3.71 
DL-3-phenyllactic acid 2.34 14.0 1.63 9.82 2.78 16.7 1.44 8.69 




Fig. 8. Comparisons of the eluents from the CF obtained using Amberlite IRA-67 
and CF of Lb. plantarum LBP-K10. Similar profiles of the CDPs of the eluents from 
the organic acid- or sugar-removed CF after the use of Amberlite IRA-67 or Purolite 
A420S and intact CF of Lb. plantarum LBP-K10.  
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2. 3. 5. Bioactivity of K10-CCDP against microbial and viral pathogens 
K10-CCDP was observed to have significant antibacterial activity against reference 
strains and multidrug-resistant bacteria and its concentration that was required for 
bioactivity were shown by the types of the primary AECs (Table 11 and Table 12). In 
the case of the antibacterial activity of K10-CCDP-I against S. aureus 11471, S. 
pneumoniae 14596 and S. typhimurium 12219, the active cis-cyclo(L-Leu-L-Pro) (F13) 
levels in K10-CCDP-I were observed to be 0.27, 0.28 and 0.25 mg/l, respectively (Tables 
9 and 112), which were revealed to be extremely lower than the active concentrations of 
21.67, 21.25 and 7.40 mg/l for cis-cyclo(L-Leu-L-Pro) as a single compound (Table 7). 
These active cis-cyclo(L-Leu-L-Pro) (F13) concentrations in the K10-CCDP 
corresponded to decreases ranging from 30.77-, 25.94- and 41.25- fold to 90.10-, 75.96- 
and 120.79- fold for the dosages of K10-CCDP-I, K10-CCDP-II and K10-CCDP-III, 
respectively, compared to the use of the single cis-cyclo(L-Leu-L-Pro) (Tables 9, 10, 12 
and Table 7 ). Cyclo(L-Pro-L-Tyr) and cyclo(D-Pro-L-Tyr) from Streptomyces sp. strain 
22-4 were observed to be active against Xanthomonas axonopodis pv. Citri and Ralstonia 
solanacearum (Wattana-Amorn et al. 2015) with MIC of 31.25 mg/l, which 
corresponded to 1.09, 1.85 and 1.1 mg/l cyclo(Tyr-Pro) of three types of K10-CCDP 
(Table 10). Additionally, 12.5 mg/l cis-cyclo(L-Leu-L-Pro) from MIC values or the 
synergistic activity by the combination of CDPs using two types of proline-based CDPs 
against VRE strains, including E. faecium (vanA, vanB), and E. faecalis (vanA, vanB) 
with MIC values of 0.25–1 mg/l, and also against E. coli, S. aureus and M. luteus, were 
also significantly higher than that of single cis-cyclo(L-Leu-L-Pro) or cis-cyclo(L-Phe-
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L-Pro) and K10-CCDP although the different pathogenic strains were used for 
antimicrobial activity (Rhee 2002). 
The proliferation of G. boninense and C. albicans was also inhibited by treating 
three types of K10-CCDP (Table 12). The anti-Ganoderma or anti-Candida activity 
displayed 7.27-, 62.66 and 61.45-fold and 13.48-, 95.81- and 83.57-fold remarkably 
lower than 1.67 and 1.25 mg/l cis-cyclo(L-Phe-L-Pro) that were measured in our 
previous investigation (Kwak et al. 2014). Moreover, these active concentrations of 
K10-CCDP for fungal pathogens were also significantly lower than 20 mg/ml for 
cyclo(L-Ile-L-Pro) from the MIC values (Lind et al. 2007) and similar concentrations, 
as reported previously for cyclo(L-Phe-L-Pro), against Fusarium sporotrichioides or A. 
fumigatus (Ström et al. 2002). Morevoer, the antifungal activity of three types of K10-
CCDP was more effective than the synergistic activity of lactic acid, cyclo(L-leu-L-pro) 
and cyclo(L-phe-L-pro) from Lb. casei AST18 (Li et al. 2012). Interestingly, even 
though it was observed that the combined effects of cyclo(L-leucyl-L-prolyl) and 
cyclo(L-phenylalanyl-L-prolyl) were especially effective against C. albicans and C. 
neoformans with MIC values of 0.25-0.5 mg/l , these active levels were also revealed to 
be extremely higher than those of K10-CCDP (Table 12). 
Thus, the active concentration of each CDP in K10-CCDP was observed to be 
substantially lower than that in other previous studies that investigated the bioactivity of 
a single CDP or a certain of combination of CDPs against various bacterial or fungal 
pathogens. Furthermore, the active concentration of each CDP in K10-CCDP against 
influenza A virus (Table 13) suggests that K10-CCDP-III, which contained significantly 
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lower active concentrations of each cis-cyclo(L-Leu-L-Pro) or cis-cyclo(L-Phe-L-Pro), 
was observed to have more potent antiviral activity compared to other two types of K10-
CCDP similar to antibacterial and antifungal activity.  
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Table 11 Antibacterial activity of K10-CCDP 
Indicator strains Active concentration of complex, MIC (mg/l)* 
 K10-CCDP-I K10-CCDP-II K10-CCDP-III 
Gram-positive bacteria  
Bacillus subtilis 16.3 17.5 12.7 
Staphylococcus aureus 16.3 
17.5 12.7 
Streptococcus pneumoniae 16.3 
17.5 12.7 
Gram-negative bacteria  
  
Escherichia coli 12.5 
13.7 11.9 
Salmonella typhimurium 
12.5 13.7 11.9 
Shigella dysenterii 
12.5 13.7 11.9 
* The values represent the average of three independent experiments. 
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Table 12 Comparison of the antimicrobial activity of K10-CCDP against multidrug-
resistant bacteria and pathogenic fungi 
Multidrug-resistant strains 









Staphylococcus aureus 11471a 18.5 18.7 12.4 
pneumoniae 14596 a 19.4 19.6 13.0 
Salmonella Typhimurium 12219 b 17.2 17.4 11.5 
Fungal strains 









Plant pathogen    
Ganoderma boninense 37.0 34.0 24.8 
Human pathogen    
Candida albicans 20.3 22.7 18.6 
Multidrug-resistant a Gram-positive and b Gram-negative bacteria supplied by the 
Korea National Institute of Health. 
c The values represent the average of three independent experiments.  
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 76.6  5.7 (8) 0 
 82.1  3.4 0 






K10-CCDP-I 71  2.6 (8) 7.31 
K10-CCDP-II 76.2  2.6 7.19 
K10-CCDP-III 73.4  6.5 10.08 
1.0 
(14.352) 
K10-CCDP-I 46.3  4.6 (8) 39.56 
K10-CCDP-II 50.4  4.1 38.61 
K10-CCDP-III 43.1  5.5 45.72 
1.5 
(21.528) 
K10-CCDP-I 34.6  6.1 (8) 54.83 
K10-CCDP-II 40.5  4.7 50.67 
K10-CCDP-III 32.7  4.2 58.82 
2.0 
(28.704) 
K10-CCDP-I 25  2.6 (8) 67.36 
K10-CCDP-II 29.2  2.9 64.43 
K10-CCDP-III 24.9  4.6 71.17 
a The values represent the average of three independent experiments. 
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2. 4. Discussion 
It has been widely reported that bioactivity-based studies have been steadily updated 
to reflect the beneficial effects of CDPs from Lactobacillus spp. because of their rigid 
structure, quorum sensing and various physiological functions in organisms ranging 
from bacteria to humans (Wang et al. 2013). Hence, synthetic CDPs have been also 
suggested as strong candidates for drug design and human disease therapeutic 
applications (Borthwick 2012). However, although synthetic CDPs also seem likely to 
have potency, oral bioavailability and to be selective small molecules, the abiotic 
synthesis of CDPs has partially faced knowledge acquisition bottlenecks, such as 
complicated or expensive coupling reagents (Hulme and Gore 2003), difficult 
cyclisation (Martins and Carvalho 2007), synthesis that is mostly limited to small-scale 
solution (Dinsmore and Beshore 2002) and solid-phase reaction conditions (Fischer 
2003). For this reason, high-throughput purification methods to obtain CDPs from CFs 
might be able to compensate for some of the difficulties in producing synthetic CDPs 
from the CFs. Moreover, a global CDP profile or a method for high-throughput 
quantitative purification of CF CDPs has not been obtained until now. Therefore, our 
current research aims to elucidate the CDP pool and its inhibitory effect against microbes 
and to develop an original method for the purification of the entire set of CDP analogues 
naturally present in the CF of LAB (Fig. 1). 
It was suggested that the identical HPLC chromatographic pattern of the total pool 
of CDPs was commonly associated with excreting CDPs produced by LAB. The amount 
of all CDPs particularly increased to a greater extent in Lb. plantarum LBP-K10 cultures 
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than in those of other isolates. The present study also verified that the combination of 
CDPs exhibited a significant higher antibiotic activity against several types of pathogens 
compared with that of single CDPs. Although the bioactivity of single CDP was shown 
to be slightly similar to previous investigations, the active concentration of each 
compound in K10-CCDP was observed to be remarkably lower than that of the combined 
CDPs previously. These findings can provide a framework for future research or 
commercial fields such as agricultural pesticide, natural preservatives or animal feed 
additives and suggest the capability to assess the antibiotic effects of CDPs and their 
possible applications. In the case of the culture supernatant derived from this isolated 
strain, as shown in the CDPs content of the CFs (Tables 9 and 10), the LAB culture itself 
might be used in the feed stock containing various kinds of CDPs for domestic animals 
as eco-friendly feed stuff. Therefore, this study demonstrated that the single CDPs were 
bio-effectors but that the groups of CDPs could also exert potent bioactive effects against 
various types of pathogens. It has been also reported that the combination of CDPs could 
exert synergistic effects against microbes (Kwak et al. 2013). However, although the 
MIC and antagonistic effects were observed for each of the individual CDPs purified 
from Lb. plantarum LBP-K10 CFs in this study, we could not observe the combined 
mixtures of single CDP with each other due to the limitation of collecting each CDP by 
using a semi-preparative HPLC system. Hence, we had to consider the hypothesis on 
preparation of a massive amount of the complete set of CDPs from LAB CFs. 
Herein, several types of fractions were observed to contain the same CDP, as 
indicated by the EI/CI data from GC-MS, despite these molecules being present in 
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separate peaks in the HPLC chromatograms (Fig. 6 and Table 4). This result suggests 
that the differences in retention times (ΔtR) of CDPs might be derived from the 
conformational enantiomeric pair or diastereomers, which were formed by an 
intramolecular hydrogen bond between the carboxy and carboxyamide in the possible 
cyclic dipeptidyl moiety (Brückner and Keller-Hoehl 1990). It was also demonstrated 
that the folded structures for instances of five diastereomeric pairs [c-(L-X-L-Y) and c-
(L-X-D-Y)] were proposed to influence retention behaviour and lead to the separation 
of diastereomers on an reverse phase-HPLC column (Funasaki et al. 1993). In the case 
of cyclo(L-Ala-D-Ala), it was separated from the enantiomeric pair cyclo(L-Ala-L-Ala) 
and cyclo(D-Ala-D-Ala) in 10 % methanol-contained mobile phase as proposed 
(Perzborn et al. 2013). Importantly, it was also suggested that the energy barrier to 
interconversion might be so high as to permit chromatographic separation of 
enantiomeric pair or diastereomers particularly of proline-containing peptides (Swadesh 
2000). These previous reports presumably inferred that the isolated F1/F6/F11, F2/F9, 
F3/F4/F12/F13, F5/F7 and F16/F17 might be enantiomeric pair of the factions in this 
study (Table 4). Thus, our experimental results seemed to be the chromatographic 
fractionation of the racemic substances of the diastereomers, which could be entirely 
fractionated by MC extraction. However, other researchers have reported the antibiotic 
functions of bacteriocins and bacteriocin-like substances in the CFs from various types 
of LAB strains (Caplice and Fitzgerald 1999). Nevertheless, after the MC extraction of 
samples from repeated HPLC separation, all cases of isolated CDPs were sufficiently 
pure to be analyzed by GC-MS-EI/CI as one compound because any contaminant or 
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other substances were not observed under all experimental conditions (Fig. 4), indicating 
that the MC extraction of the CF was a purification method with strong selectivity for 
CDPs. Moreover, other experimental methods, such as 2D LC-MS/MS ESI at high- or 
low-resolution, did not show bacteriocin-like molecules (data not shown). Therefore, in 
this study, we focused on the purification of single CDP or sets of CDPs because we did 









3. 1. Aims 
 The breast track cancer prevention effect of oral administration of CF-
K10 
 The breast cancer prevention effects of MC-K10 
 The effect of MC-10 and cyclo(Phe-Pro) on breast cancer stem cells  
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3. 2. Material and methods 
 
3. 2. 1. Cancer cells 
Human breast cancer cell MDA-MB-231 (ATCC, Manassas, VA) were maintained 
in Dulbecco's Modified Eagle's Medium (DMEM; Gibco BRL, Grand Island. NY) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS, Gibco), penicillin 
(100 U/ml, Gibco) and streptomycin (100 µg/ml, Gibco) at 37 °C in a CO2 atmosphere. 
 
3. 2. 2. Culturing and identifying lactic acid bacteria 
CF-K10 were isolated, cultivated and identified as described in chapter II. 
 
3. 2. 3. MC-K10 and cyclo(Phe-Pro) collection 
The supernatant from three-day cultured Lb. plantarum LBP K-10 was collected by 
centrifugation, lyophilised, extracted with with 2-fold volumes methylene chloride (MC). 
After the methylene chloride fraction was evaporated, the residue were dissolved with 
distilled water, this mixture were named as MC-K10. To obtain cyco(Phe-Pro), MC-K10 
were filtrated with a 0.22 µm-cellulose acetate membrane, and were separated using a 
semi-preparative HPLC system (Agilent, USA) with a semi-preparative Hypersil ODS 
C18 reverse-phase column (9.4  250 mm, Agilent, USA) and the ChemStation HPLC 
software. 
 
3. 2. 4. Animal studies 
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All mouse studies were performed in accordance with protocols approved by the 
Animal Care and Use Committee at Southeast University (Approval ID: SEU-20150615-
3). SCID mice were housed under pathogen-free conditions and were given autoclaved 
food and water. After determining the cell viability by trypan blue exclusion test, 2 × 106 
MDA-MB-231 cells were injected into mammary fat pad in a 100 µl volume of sterile 
phosphate-buffered saline. SCID mice were used as 6 weeks of age and 10 mice for each 
group. CF-K10 were diluted 5 times with drinking water and given to the mice on the 
first day of cell transplantation. Tumors were measured using precision calipers twice 
weekly. Tumor volume was calculated at: volume = (length × width2)/2. 
 
3. 2. 5. Flow cytometry 
After 3 washes with PBS, cells that were treated with MC-K10 or CDP and intact 
cells were detached with trypsin (Gibco) for 10 min at 37 °C. For cell surface antigen 
phenotyping, floating and detached spindle-shaped cells were stained with fluorescent 
antibody CD133 (Becton–Dickinson, San Jose, CA, USA). Analyses were performed 
with FACS Calibur (Becton–Dickinson, NY, USA). 
 
3. 2. 6. Cell-cycle analysis 
2 × 106 cells were fixed in cold methanol, RNase-treated, and stained with propidium 
iodide (Sigma). Cells were analyzed for DNA content by EPICS-XL scan (Beckman 
Coulter) by using doublet discrimination gating. All analysis were performed in triplicate 
and 20,000 gated events/sample were counted. 
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3. 2. 7. Cell viability assay 
Hoechst 33342 (Sigma-Aldrich, St. Louis) and Propidine Iodide (PI; Sigma-Aldrich) 
were used for staining cells treated in the mentioned condition following follow the 
method described before with slight modifications (Zhu et al. 2006). Cells were fixed 
for 30 min in phosphate-buffered saline (PBS) containing 1 % glutaraldehyde. After 
fixing at room temperature, the cells were washed twice with PBS and then exposed to 
5 μg/ml Hoechst 33342 in PBS for 30 min at room temperature. The cells were then 
further incubated with 1 μl PI and were immediately observed using a fluorescence 
microscope. 
3-4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) 50 µl of 
2 mg/ml in 1× PBS was added to each dish, and the indicated cells were incubated for 4 
h at 37 °C. The plates were then centrifuged at 500 × g for 10 min, and DMSO (120 µl, 
Sigma) was added to each well and incubated 1 h on an orbital shaker. The A570 nm 
was determined using an ultra-microplate reader (ELx 808; Bio-Tek Instruments, 
Winooski, VT). 
 
3. 2. 8. Western blot analysis 
Protein was extracted from the cells after culturing in the indicated conditions. After 
measuring the protein concentrations of homogenized lysates, 10 µg of protein extracted 
from cancer cells was separated by 10 % SDS–PAGE and transblotted onto a 
polyvinylidene fluoride (PVDF) membrane. After blocking in a powdered nonfat milk 
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solution (5 % in PBS) with 0.05 % Tween-20, the blot was incubated with a polyclonal 
rabbit anti- human Bcl-2-associated death promoter (BAD) antibody (Cell Signaling, 
Danvers, MA), a rabbit anti- human caspase-3 antibody (Cell Signaling), a rabbit anti- 
human Bcl-2 antibody (Cell Signaling), a rabbit anti- human Cytochrome C antibody 
(Cell Signaling), a rabbit anti-human CD133 antibody (Cell Signaling), a rabbit anti-
human Oct4/3 antibody (Cell Signaling) and a rabbit anti-human beta– actin antibody 
(Cell Signaling) at 1∶1000 dilutions in 5 % blocking solution over night at 4 °C. An 
anti-rabbit IgG antibody at a dilution of 1∶5000 was used as a secondary antibody. The 
results were detected with an enhanced chemiluminescence kit (ECL; Amersham 
Bioscience/GE Healthcare, Little Chalfont, UK). 
3. 2. 9. Sphere- forming assays
Cell monolayers were trypsinized to generate single-cell suspensions and counted by
a hemocytometer. Single-cell suspensions (105 cells per 100 mm dish) were plated with 
an ultralow attachment surface. Three dishes were seeded for each cell line, and triplicate 
experiments were performed. Tumor spheres were counted and images of each well were 
taken on day 9. Immediately after the cells were seeded, each well was checked under 
the microscope to verify the sparseness of each spherical culture, and only wells 
containing single-cell suspension with no cell cluster were chosen for tumor-sphere 
counting after 9 days. Colonies of at least 60 µm in diameter (determined by using an 
eyepiece gratitude with crossed scales) were counted on day 9 after plating. 
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3. 2. 10. Statistical analysis 
Data are presented as means ± standard error (SD) in quantitative experiments. The 
differences between groups were analyzed using the unpaired Student's test. P values 
<0.05 were considered significant.  
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3. 3. Results 
 
3. 3. 1. Breast cancer prevention effect of CF-K10 in mouse model. 
After centrifuging, the cell-free CF-K10 was diluted 5 times with drinking water. 1 
× 106 MDA-MB-231 cells were injected in mammary fat pad of the mice. 20 % CF-K10 
water was supplied on the first day of cancer cell transplantation. On the day of 31st, the 
volume of the tumors in CF-K10 supplied group was significantly smaller than that in 
the positive control group. Actually, the obvious cancer inhibition effect could be 
observed on the 10th day after cell transplantation, and this inhibition effect become 
significant on the day 17, meanwhile the tumor growth rate increased during the same 
time period. However, though CF-K10 water was cautiously supplied till the 31st day, 
the tumor sizes were arrest since the 17th day, while tumors keep growing in the positive 
control group (Fig. 9).   
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Fig. 9. CF-K10 inhibited the progress of in situ breast cancer progression in 
mouse model. 
20 % CF-K10 diluted with drink water was supplied as daily drink water for the first 
day of transplantation of MDA-MB-231 cells in mammary fat pad of SCID mice. As 
early as on the 17th day, the volume of tumor was obviously different. On the 31th day, 
the volume of tumor showed a significantly difference between the 20 % CF-K10 
supplied group and drink water supplied control group.
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3. 3. 2. CF-K10 induced cell death on breast cancer cell. 
The in vivo studies encouraged us to exploring the mechanism of breast cancer tumor 
prevention effect of the CF-K10. First, we treat the triple negative breast cancer cell line 
MDA-MB-231 with CF-K10. Majority of cells were lysed in vitro when cultured in 
conditions with more than 5 % CF-K10 supplement (Fig. 10). The viability of cancer 
cells were quantified with MTT assay, around 80 % of cancer cell could survive after 3 
days with the treatment of 3 % CF-K10, and only 30 % of cells could survive in 5 % 
treatment (Fig. 11A). Further studies were executed in 3 % CF-K10. The cell cycle states 
were checked with FACs (Fig. 11B). The expressions of proteins that are evolved in 
apoptosis pathway, BAD, BCL-2 and cytosolic cytochrome C were examined with 
western blot. The results showed the expression of cytosolic cytochrome C and BAD 
were increased while BCL-2 expression level was decreased (Fig. 11C).The results 






Fig. 10. CF-K10 induced apoptosis in breast cancer MDA-MB-231 cells. 
Serial concentration of CF-K10 was employed to treat MDA-MB-231 breast cancer line. 
Hoechst 33342 (blue) and PI (red) staining were performed for identifying the death of 
cancer cells. Majority of cell dead with the treatment of 5 % CF-K10.
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Fig. 11. CF-K10 induced cell growth arrest and activated apoptosis pathway. 
MTT assay were performed to verify the cell viability in the present of different 
concentration of CF-K10. Only 5 % cancer cell survived in 5 % CF-K10 supplement 
condition (A). After three days of treatment of 3 % CF-K10, the 63.8 % of cells arrested 
in G2/S phase (B). The expression of apoptosis pathway related proteins were examined 
by western blot. The increasing expression of cytosolic cytochrome C and BAD and the 
decreasing expression of BCL-2 indicated CF-K10 induced the activation of apoptosis 
pathway in cancer cells (C).
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3. 3. 3. CDPs complex effectively induced breast cancer cell apoptosis. 
Our previous studies have displayed Lb. plantarum LBP-K10 isolated from 
fomented food produce several kind of CDPs. Single CDP components or MC-K10 has 
been proved to have antimicrobial effect even though the mechanisms was not well 
clearly elaborated yet. Since studies also proved that CDPs are capable of inducing 
cancer cell apoptosis, we wondered whether the MC-K10 derived from Lb. plantarum 
LBP-K10 possessed anticancer effect. 
Separated MC-K10 was diluted to the original volume of CF-K10 with PBS. This 
solution was diluted with PBS as mentioned in further studies. Serial dilutions were 
tested on cancer cells. As shown in MTT assay, 57 % cancer cell can survive in 20 % 
MC-K10 supplement conditions, however, only around 10 % cancer cell can survive in 
40 % MC-K10 supplement conditions (Fig. 12A). We further tested the expression of 
apoptosis related proteins, capase-3 and cytosolic cytochrome C. the expression of both 
proteins were elevated when the cells treated with 20 % MC-K10 (Fig. 12B). To further 
confirm caspase-3 pathway involved in MC-K10 induced apoptosis, Ac-DEVD-CHO, 
an inhibitor of caspase-3, were employed in MC-K10 treatment group. As a result, the 
survival rate was reversed to 82 % (Fig. 12C). These results indicated MC-K10 isolated 
from CF-K10 could induce breast cancer cell apoptosis through caspase-3 pathway.  
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Fig. 12. MC-K10 induced caspase-3 dependent apoptosis in breast cancer cells. 
Serial dilutions of MC-K10 with PBS were employed to treat cancer cells. MTT assay 
was performed to examine the viability of cells. The trend line also was also shown along 
with the column diagram. More than half of the cells can survive when the concentration 
of MC-K10 was less than 20 % (A). 
Western blot showed caspase-3 elevated along with the increasing expression of 
cytosolic cytochrome C (B). 
The cell viability reversed when caspase-3 inhibitor, Ac-DEVD-CHO was supplied in 
20 % MC-K10 treatment group (C).  
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3. 3. 4. Cyclic dipeptides produced by Lb. plantarum LBP-K10 impaired cancer 
stem cells viability and tumor formation ability. 
Cancers are initiated and maintain by cancer stem cells. Substance that can 
effectively shrink the tumor volumes may be resistance by cancer stem cells. Our in vivo 
and in vitro study encouraged us to test the effect of cyclic dipeptide CDP on cancer 
stem cells. As the most abundant component existing in CDPs, cyclo(Phe-Pro) was 
separated and purified this test. Serial sphere formation assay was performed. In the first 
passage of sphere formation test, the sphere formation ability was 43 % in cyclo(Phe-
Pro) treated group when comparing with control group. However, the sphere formation 
ability in MC-K10 was significantly decrease to 45 %. There is a significant difference 
in sphere formation ability between passage-1 and passage-2 in cyclo(Phe-Pro) treated 
group, whereas , this sphere formation ability are comparable between passage-2 and 
passage-3 as around 40 %. The sphere formation of MC-K10 treated group was 
continuously decreased in passage-2 and passage-3 (Fig. 13A). Since CD133 was 
regarded as cancer stem cell marker, the partition of CD133+ cells was analyzed. CD133+ 
cells were decrease dramatically in MC-K10 treated group (Fig. 13B). We next 
examined another cancer stem cell marker, Oct4 and quantified the western blot results. 
Oct4 expression were decreased in both cyclo(Phe-Pro) and MC-K10 treated group. 
Compare with cyclo(Phe-Pro) treatment, the expression of Oct4 was dramatically down 
regulated (Fig. 13C and D). These results indicated MC-K10 could induce the stemness 
and self-renew ability of breast cancer stem cells.
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Fig. 13. Cyclic dipeptides impaired cancer stem cell activity. 
10 mM cyclo(Phe-Pro) or 20 % CDPs was employed to treat MDA-MB-231 cells and 
the sphere formation ability was examined. Both the single cyclo(Phe-Pro) and MC-K10 
were capable of impairing sphere formation, though MC-K10 showed a more strong 
inhibition activity(A). CD133+ cell decreased dramatically in MC-K10 treated group, 
and due to few cells could obtain in passage-3, FACs was not possible performed in MC-
K10 treated group. However, the CD133+ cell partition in passage-2 and passage-3 was 
comparable in cyclo(Phe-Pro) treated group(B). Passage-2 sphere were lysed to examine 
the expression of Oct4 (C). 
The western blot results of (C) were quantified. MC-K10 treatment significantly 
diminished the expression of Oct4 than cyclo(Phe-Pro) treatment, though cyclo(Phe-Pro) 
also can induce a dramatic decreasing expression (38.4 %) of Oct4 when comparing with 
intact control group (D).  
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3. 4. Discussion 
LAB can survival in acid environmental and resist to the digest effect of bile, thus, it 
can pass through the GI track and adhere on the intestine cells. Since colon cancer is one 
of the major types of GI track cancer and LAB may directly interact with colon cancer 
in GI tack, studies focus on the anti-colon cancer effect of live LAB. Several mechanisms 
have been revealed. Very few studies investigated the effect of LAB or it product on 
non-GI track cancer. Previously, we confirmed a special set of cyclic dipeptide complex 
producing by Lb. plantarum LBP-K10, which give a strong effect of anti-microorganism. 
Despite the anti-microorganism effect, other studies confirmed cyclic dipeptides are 
capable of induce cancer cell apoptosis. Most importantly, studies revealed the quickly 
absorption of cyclic dipeptide in animal. Therefore, we purposed that oral up taking CF-
K10 might inhibit the growth of non-GI track cancer, for example breast cancer. This 
study proved that oral in taking CF-K10 may effectively arrest the growth of breast 
cancer cell growth in animal model. 
CF-K10 contained a large amount of organic acid that contribute to cancer 
prevention effect of Lb. plantarum LBP-K10, such as butyrate acid. Since the anticancer 
effect of organic acid has been well elaborated, we further tested the anticancer effect of 
MC-K10 secreted by Lb. plantarum LBP-K10. Consistent with the report and as our 
expectation, MC-K10 can effectively inhibit the growth of breast cancer cell. 
Previously, we tested the effect of sodium butyrate, which is one of compound of 
organic acid complex produced by Lb. plantarum LBP-K10, on breast cancer prevention. 
The results indicated CMET expression in MDA-MB-231 may help the cancer cell to 
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resist sodium butyrate treatment. As a result, sodium butyrate treatment on MDA-MB-
231 is difficult to eradicate breast cancer since the resistance effect of cancer stem cells 
on it. In this study, we interest on the effect of MC-K10 on cancer stem cells. Our results 
indicated MC-K10 treatment or the major compounds in this Lb. plantarum LBP-K10 
conditioned CDPs, cyclo(Phe-Pro) may induce the apoptosis of breast cancer stem cells. 
However, the mechanisms need to be emphasized in detail, the in vivo result display that 
CF-K10 could not totally eradiated breast cancer, this may give a clue that another 
population of cancer stem cells may exist. Further studies need to be done for discovering 
the mechanism beneath these results. 
Above of all, we proved that oral administration CF-K10 was helpful for inhibit the 
growth of in situ breast cancer in mouse model and CDPs participated in this inhibition 
effect. MC-K10 and cyclo(Phe-Pro) are capable of inducing apoptosis of cancer cells. 
Our study displayed the inhibition effect of CF-K10 on breast cancer by oral 
administration and CDPs administration produced by Lb. plantarum LBP-K10 was 




A novel cyclic dipeptide synthase (CDPS) in  
Lb. plantarum LBP-K10  
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4. 1. Aims 
 
 CDPs synthesis through CDPS pathway 
 Determination of CDPS amino acid sequence 
 Overexpression of recombined CDPS and CDPs synthesis function 
examination in vivo 
 Over all CDPS Structure determination  
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4. 2. Material and methods 
 
4. 2. 1. CDPS purification from Lb. plantarum LBP-K10 
The cultured cells were harvested by centrifugation at 12,000 rpm for 20 min and 
cell pellet was resuspended in 50 mM Tris-HCl buffer at pH 8.0 containing 1.0 mM 
phenylmethanesulfonylfluoride. The cell wall was disrupted by sonication using a W-
225R Sonicator (Heat Systems-ultrasonics, Inc) with an appropriate amount of lysozyme 
(Sigma) at 30 sec each at a setting of 2.5 for 3 h on ice after repeating 10 times of the 
thawing and refreezing cell pellet. The resulting supernatant was collected by 
centrifugation and was used to purify CDPS. CDPS of cytosolic fraction was separated 
by DEAE-sepharose CL-6B by increasing the ionic strength of the eluting buffer ranging 
from 0 to 500 mM NaCl at 4 °C. Each fraction was used to react with amino acids and 
ATP as substrates. MnSO4 and MgSO4 were also used to be minor compounds similar 
to the enzymatic conditions of Lactobacillus cultures. All solutions were prepared with 
the deionized and filtrated water (resistivity 18.2-MΩ cm at 298 K Milli-Q, Millipore). 
 
4. 2. 2. CDPS activity assays 
The CDPS activity was spectrophotometrically at 340 nm or fluorometrically 
measured by ninhydrin (2, 2-Dihydroxyindane-1, 3-dione) reaction with amino acids, 
which can cause to form chromophores, particularly using a method for activity staining 
after native PAGE with modifications (Shaykh et al. 1983, Friedman 2004). The 40 ml 
CDPS assay mixture for enzyme reactions consisted of 1.0 mg/ml CDPS and 1.0 mM 
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each of the amino acids, which were the combination of two amino acids link together 
to form CDPs, in 50 mM Tris-HCl, pH 8.0, respectively. CDPS activity was observed 
by the native PAGE using protein staining with ninhydrin. In both cell crude extract and 
the fractions of eluents driven by several types of column chromatographies. The native 
PAGE was performed and the resulting gels were briefly equilibrated with 50 mM Tris-
HCl, pH 8.0 after rinsing in TDW twice for 10 min, respectively. Then, the gels were 
soaked with the reactant containing various types of amino acid pairs equilibrated with 
50 mM Tris-HCl, pH 8.0. The resulting gels were stained with 25 mM ninhydrin and 
further incubated for 2 h. The archromatic bands were observed on native gels. Because 
the amino acids near CDPS were dehydrated, condensated and cyclized into CDPs, 
which lost the amino group, the achromatic bands could be shown as a blue or brown 
color. In contrast, other parts of the ninhydrin-based stained gels where did not show 
CDPS. 
 
4. 2. 3. HPLC analysis 
Active fractions containing CDPs resulting from enzyme reactions were 
concentrated by lyophilization and extracted with methylene chloride. After the 
elimination of methylene chloride by evaporation, the resultant was dissolved in distilled 
water and filtrated with a 0.22 μm-cellulose acetate membrane (Milli-Q, Millipore). The 
filtrated samples were separated by a high-performance liquid chromatography (semi-
prep HPLC system, Agilent 1200 series) system with a semi-preparative C18 reverse-
phase column (9.4 × 250 mm, Agilent, USA) and the ChemStation HPLC software using 
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UV absorbance with wavelengths at 210, 260 and 280 nm, respectively, as proposed 
previously (Kwak et al. 2013). 
 
4. 2. 4. Overproduction of CDPS in E. coli 
The gene sequence of CDPS with a calculated molecular weight of 26.1 kDa was 
amplified by polymerase chain reaction (PCR) using Lb. plantarum LBP K-10 genomic 
DNA as a template. The cloning of CDPS gene of Lb. plantarum LBP K-10 for PCR 
amplification was conducted by utilizing PCR primers as follows: 5’-
CATATGGCAAAATTAGTATTGATTCGTCACGGT-3 (NdeI site, forward) and 5- 
GGATCCTTATTTGCCTAACTTTTCCTTACCAAG-3 (BamHI site, reverse) (NCBI 
accession number NP-391912.1). PCR amplification was performed with a Biometra 
thermocycler (Tampa, USA) for 30 cycles using amplification mixture contained 100 ng 
of genomic DNA, 0.5 μM of primer DNA, 0.2 mM dNTPs, 10 × Ex Taq buffer solution, 
and Taq polymerase (TaKaRa Bio Inc., Japan) 0.025 U/μl. PCR conditions were setted 
at 30 sec of denaturing at 95 °C, 30 sec of annealing at 55 °C, and 1.5 min of extension 
at 72 °C. The PCR products was digested with NdeI and BamHI and inserted 
downstream of the pGEM T-easy vector (Promega). The resulting ligate was 
transformed to E. coli DH5α cells. The resulting pGemT Easy-CDPS construct was 
digested with NdeI and BamHI. NdeI- and BamHI-digested 690 bp CDPS gene was 
inserted into the pET3a (+) vector using TaKaRa’s Mix ligation kit (TaKaRa Bio Inc.) 
the ratio of insert to vector was 5:1 (mole). After the ligation at 4 °C for overnight, the 
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E. coli BL21 (DE3) was used to transform the pET3a (+) vector containing Lactobacillus 
CDPS. The pET3a (+)-CDPS/BL21 (DE3) was incubated in LB (pH 7.4) with 50 μg/ml 
of ampicillin, while the control group BL21 (DE3) was incubated in LB (pH 7.4) (37 °C, 
overnight) to obtain the seed cultures. 1 % (v/v) pET3a-CDPS/BL21 (DE3) culture was 
introduced to the LB (pH 7.4) added with 50 μg/ml of ampicillin and the control group 
BL21 (DE3) in LB (pH 7.4), and incubated (37 °C, 220 rpm) for 2-2.5 h until the optical 
density reached a value of 0.4-0.5 at 600 nm. At the optical density points, isopropyl-
beta-d-thiogalactopyranoside (IPTG, final concentration 1 mM, Sigma, USA) was added 
and further cultured to induce the CDPS protein synthesis (30 °C, 150 rpm, 4-6 h). 
 
4. 2. 5. Purification of CDPS in E. coli 
The transformed pET3a-CDPS in BL21 (DE3) was cultured, harvested, centrifuged 
at 8,000 × g, 4 °C for 20 min. The cells were dissolved in lysis buffer, which consist of 
50 mM Tris-HCl buffer, pH 8.0 at a ratio of 1:9 (w/v), 1 mM PMSF, and the cells was 
sonicated on ice for 5 min. After the cell debris was discarded by centrifugation at 
12,000×g, 4 °C for 20 min), the filtrates was collected in a fresh tube and was used as an 
extract solution (Kanda et al. 1997). The quantity of protein was determined by the 
Bradford method (Bradford 1976) using the Bio-Rad protein assay reagent (Bio-Rad, 
USA). The resulting filtrates was loaded onto phenyl sepharose equilibrated with 1.0 x 
103 mM ammonium sulfate. After the column was washed with the same buffer, the 
bound protein was eluted with a reverse linear gradient ranging from 1.0 x 103 to 0 mM 
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ammonium sulfate in 50 mM Tris-HCl buffer at a flow rate of 3ml/min. The resulting 
fractions were tested by native-PAGE using ninhydrin followed by combining and 
concentrating by ultrafiltration using PM10 membrane (Amicon). Subsequently, the 
concentrated enzyme solution was desalted using superdex75 FPLC system with 50 mM 
Tris-HCl (pH 8.0). The CDPS was further loaded on a DEAE-sepharose equilibrated 
with 50 mM Tris-HCl (pH 8.0) buffer. The enzyme was eluted with a linear gradient of 
0-1.0 x 103 mM NaCl in the 50 mM Tris-HCl (pH 8.0) buffer. The purified enzyme was 
stored at 4 °C. 
 
4. 2. 6. 2D-LC-MS/MS analysis 
The gel spots visualized by Coomassie Blue R-250 staining were excised, followed 
by destaining and reduction/alkylation with 10 mM and 50 mM iodoacetamide 
(Shevchenko et al. 1996). Following the dehydration of gel slices with acetonitrile, two 
volumes of freshly prepared trypsin (20 ng/mL-1 in 25 mM NH4HCO3) were added and 
incubated at 37 °C for 18 h. Peptides were extracted with 10 ml of 0.1 % trifluoroacetic 
acid/ 50 % acetonitrile solution in two consecutive steps, dried through a vacuum 
centrifuge, and re-dissolved in 10 mL of 0.1 % trifluoroacetic acid. Mass analysis and 
protein identification were carried out on a ProteomeX LTQ 2D-LC-MS/MS 
spectrometer (Sinco, Inc.). The amino acid sequences were aligned using Clustal 2.1. 
 
4. 2. 7. Molecular mass determination 
 The molecular mass of the purified CDPS was determined by gel filteraion 
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chromatography on a superpose 12 GL300 (HiLoad 16/60, 1.6 x 10 cm, GE Pharmacia), 
calibrated with alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), 
cytochrome c (12.4 kDa) aprotinin (6.5 kDa) 
 
4. 2. 8. X-ray crystallography of CDPS  
The CDPS was crystallized by the hanging-drop vapor diffusion method using 24-
well costa plates at 295 K. The initial crystallization screening of CDPS was performed 
by the micro-batch method with Crystal ScreenI/II, Index, SaltRx. Natrix, Cryo, 
MembFac kits (Hampton Research, USA) and Wizard I, II screening solutions (Emerald 
Bio Systems). Droplets composed of 1 ul protein solution and equal volume of 
crystallization screening solution were loaded under layer of 1:1 mixture of silicon oil 
and paraffin oil in 72-well HLA plates (Nunc) and equilibrated at 295 K. Serval bundles 
of rod-shaped crystals were produced under the condition containing 100 mM HEPES 
pH 7.5, 50 mM magnesium chloride and 30 % polyethyleneglycol550 (PEG550) in three 
days. Then the crystallization condition was optimized with hanging-drop vapor 
diffusion method using 24-well well culture plate by adjusting from 30 % PEG550 to 16 
% PEG550. Finally, single crystal was made in droplets containing 1 µl of protein sample 
(20 mg/ml) and an equal volume of precipitant solution containing 50 mM MgCl2, 100 
mM HEPES pH 7.5 and 17 % PEG550. The droplets were equilibrated against 400 µl of 
the same precipitant solution at 295 K and crystals grew to maximum size in 7 days. 
The selenomethionyl CDPS was crystallized by the same procedures as the 
crystallization of native CDPS with a precipitant solution containing 50 mM MgCl2, 100 
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mM HEPES pH 7.5 and 17 % PEG550. Native CDPS single crystals are soaked with 5 
mM substrates (ATP, L-proline and L-phenylalaine) in crystallization condition to solve 
the cofactor binding complex structure. 
 
4. 2. 9. Antimicrobial assays of CDPs produced by recombinant CDPS 
Antimicrobial activity was investigated by using disk diffusion assay (Felten et al. 
2002).  Culture supernatant of recombinant E. coli were used and spotted on 6 mm 
paper disk (Toyo Roshi kaisha, 1td). Multidrug-resistant bacteria strains, used as 
indicator strains, was inoculated onto 1 % of the suitable molten agar. The spotted disk 
paper was putted on the agar plate and incubated 24 h at suitable temperature. 




4. 3. Results 
 
4. 3. 1. CDPS activity and its verification 
We examined the existence of CDPS by its synthesis ability in vivo. First, the crude 
extract from Lb. plantarum LBP-K10 was eluted with 300 mM NaCl through HPLC 
system and collected every hour, totally 11 fractions were obtained. Then, linear gradient 
of NaCl were performed for each fraction. After native SDS-PAGE loaded with each 
fraction was incubated with proline/Leucine or proline /phenylalanine with or without 
ATP, the gel was stained with ninhydrin. As our expectation, achromatic band could be 
observed on the blue stained gel in the ATP supplanted conditions (Fig. 14).We then 
tried to verify the generation of cyclic dipeptides. We applied all fraction of extract from 
Lb. plantarum LBP-K10 mix with amino acids and ATP. HPLC analysis confirmed the 
synthesis of cis-cyclo(L-Pro-L-Leu) and cis-cyclo(L-Pro-L-Phe). These results indicated 
the existence of CDPS in Lb. plantarum LBP-K10 conditioned medium as well as 





Fig. 14. The enzyme activity was verified by native activity staining. 
Synthesis of cyclic dipeptide, catalyzed by CDPS, resulted an achromatic band 
appearing on the blue ninhydrin stained gel (indicated with red arrows)
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Fig. 15. HPLC analysis of cyclic dipeptides in reaction solution including enzyme 
and substrates. Enzyme catalyzed L-Proline/L-Leucine/L-Phenylalanine mixture to 
generating new substances, which were shown as peaks appeared after 9.7 min with 
present of ATP (A; Bond black line). However without ATP, Enzyme could not catalyze 
any reaction in the CDPS/L-Proline/ L-Leucine/L-Phenylalanine mixture (A; Dot line). 
Solutions contained the enzyme only were applied as control (A; Dash line). cis-cyclo(L-
Pro-L-Leu) (B; MW 210) and cis-cyclo(L-Pro-L-Phe) (C; MW 244) were examined with 
HPLC, and the results indicated the existence of two cyclic dipeptide in the Enzyme/ L-
Proline/ L-Leucine/ L-Phenylalanine mixture after reaction (Bond black line).  
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4. 3. 2. 2D-LC-MS/MS of Lb. plantarum LBP-K10 CDPS 
According the results mentioned above, we confirmed the synthesis active native 
activity staining of fraction 5-11, which present a strong activity in figure14. The 
synthesis capability was increased and reach the strongest activity in fraction 9. 
Afterwards, the activity was gradually decrease (Fig. 14). Then, proteins fraction 5-11 
were separated on SDS page for examine the candidate protein worked as CDPS. We 
proposed the synthesis activities should presented the concentration of CDPS proteins. 
Interestingly, the band indicated by red arrows present the same trends with the synthesis 
activity indicated as the band shown in A (Fig. 16).The red arrow indicated band 
(fraction 7-9) were cut and run on SDS-PAGE after stained with laemmli-staining 
method. Band of fraction 7 and 9 could be observed (Fig. 16B). Mass analysis and 
protein identification were carried out with the purified CDPS from fraction 9 band 
represented in Figure15A on ProteomeX LTQ spectrometer (Sinco, Inc). The purified 
CDPS like protein, could be identified as a polypeptide consisted of 230 amino acids 
with a calculated molecular mass 26.1 kDa (Table 1). A 690 bp of sequence from NCBI 
genome database could be obtained (Fig. 17 and Fig. 18). However, only an accession 
number as 11821150 was assigned. We then named this CDPS-like protein as cyclic 




Fig. 16. Purification of enzyme in Lb. plantarum LBP-K10. (A) An achromatic band 
(red arrow) confirmed the protein existed in fraction 7-11 possessed CDPs synthesis 
ability (please refer to Fig. 14). The bands, whose level changing corresponding to native 
staining band in 14, were screen out and indicated with red arrows. (A). Laemmli-stained 
band of fraction 7-9 (indicated with red arrow in B) presented on SDS-PAGE again, the 
band from fraction 7 and 9 could be observed.  
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Fig. 17. The nucleotide and amino acid sequence of ORF of the cyclic dipeptide 
synthesis enzyme (NCBI gi: 311821850). A 690 bp sequence of the cyclic dipeptide 
synthesis enzyme was obtained from NCBI genome database 
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K10: Lb. plantrum LBP-K10; Lb.n Lb. namurensis; Lb.p: Lb. plantarum; Lb.f: Lb. fabifermentans; St.n : Streptomyces noursei 
Fig. 18. Multiple sequence alignment of cyclic dipeptide synthetase in Lb. plantarum LBP-K10. The amino acid sequence 
deduced from the Lb. plantarum LBP-K10 cyclic dipeptide synthetase gene was aligned with other species using vector NTT9.0 
explorer clustal X program. 
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calc.   
 pI 
 Score         Description 
gi311821850 26.1 5.07 1893.40 unnamed protein product [Lactobacillus plantarum] 
gi342240618 30.9 5.20 328.45 fructose-bisphosphate aldolase [Lactobacillus plantarum WCFS1] 
gi334089837 36.4 5.54 188.77 glyceraldehyde-3-phosphate dehydrogenase [Lactobacillus plantarum] 
gi300767613 25.7 4.64 138.68 triose-phosphate isomerase [Lactobacillus plantarum subsp. plantarum ATCC 
14917] 
gi342241915 47.1 4.88 84.67 30S ribosomal protein S1 [Lactobacillus plantarum WCFS1] 
gi342242436 49.8 5.07 84.25 glucose-6-phosphate isomerase [Lactobacillus plantarum WCFS1] 
gi342243047 47.2 5.64 78.17 adenylosuccinate synthase [Lactobacillus plantarum WCFS1] 
gi342242987 39.9 5.78 67.88 inosine 5'-monophosphate (IMP) dehydrogenase [Lactobacillus plantarum WCFS1] 
gi376010934 48.2 5.39 54.85 glutathione reductase [Lactobacillus plantarum subsp. plantarum NC8] 
gi224831202 37.2 5.06 54.46 D-lactate dehydrogenase [Lactobacillus plantarum] 
gi342240527 25.9 5.08 51.25 glucosamine-6-phosphate isomerase/deaminase [Lactobacillus plantarum WCFS1] 
gi308180800 21.5 5.01 46.21 co-chaperone GrpE [Lactobacillus plantarum subsp. plantarum ST-III] 
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gi342241697 27.2 4.82 44.55 L-serine/threonine specific protein phosphatase [Lactobacillus plantarum WCFS1] 
gi342241415 63.1 4.83 42.45 phosphoenolpyruvate-protein phosphotransferase [Lactobacillus plantarum WCFS1] 
gi254555282 27.5 4.68 39.69 hydroxyethylthiazole kinase [Lactobacillus plantarum JDM1] 
gi300636243 62.8 5.14 26.28 unnamed protein product [Lactobacillus plantarum] 
gi46430487 33.9 4.98 25.74 L-lactate dehydrogenase [Lactobacillus plantarum] 
gi45644480 57.4 4.81 22.95 GroEL [Lactobacillus plantarum] 
gi308179245 23.8 5.02 22.56 beta-phosphoglucomutase [Lactobacillus plantarum subsp. plantarum ST-III] 
gi254556766 96.5 5.34 20.49 ATP-dependent Clp protease, ATP-binding subunit ClpB [Lactobacillus plantarum 
JDM1] 
gi2190422 40.7 5.59 19.72 alanine racemase [Lactobacillus plantarum] 
gi376008932 25.9 5.21 19.58 D-ribitol-5-phosphate cytidylyltransferase [Lactobacillus plantarum subsp. plantarum 
NC8] 
gi342242174 26.2 4.65 18.47 cell division initiation protein DivIVA [Lactobacillus plantarum WCFS1] 
gi342241708 26.6 4.93 17.97 ribonuclease III [Lactobacillus plantarum WCFS1] 
gi376009253 20.8 5.10 17.53 formylmethionine deformylase [Lactobacillus plantarum subsp. plantarum NC8] 
gi254556111 53.2 5.33 16.91 aspartyl/glutamyl-tRNA amidotransferase subunit B [Lactobacillus plantarum JDM1] 
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4. 3. 3. Activity of recombinant CDPS 
CDPS overexpression in pET3a (+) system in E. coli was firstly confirmed on SDS 
page stained with coomassie blue (Fig. 19). After the native gel loaded with CDPS was 
incubated for 4 h with several kinds of amino acids in the presence of ATP, the 
achromatic band was observed by ninhydrin staining (Fig. 19B).To confirm the 
overexpression of CDPS could result the generation of cyclic dipeptides, HPLC was 
applied for analyzing the total cyclic dipeptides produced by this gene transfected 
bacteria. According to the broad spectra of HPLC result, the expression of three L-
Proline-based cyclic dipeptides, cis-cyclo(L-Val-L-Pro), cis-cyclo(L-Leu-L-Pro),cis-
cyclo(L-Phe-L-Pro), was increased significantly (Fig. 20). After transfected with CDPS 
plasmid, the content of these fractions were remarkably increased up to 2.05-, 2.33- and 
2.56-fold (Fig. 20 and 21). To confirm the E. coli transfected with pET3a-CDPS plasmid 
are capable of producing functional CDPS, disk diffusion assay was performed 
following the same method employed for Lb. plantarum LBP-K10 as mentioned above. 
As shown in Figure 22, CDPS transfected E. coli culture filtrates displayed antibacterial 
activity against gram positive and gram negative bacteria whereas control group did not. 
These data strongly suggested that CDPS transfection in E. coli results the functional 
target CDPS expression.  
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Fig. 19. Overproduction and native activity staining of CDPS. Overproduction of 
CDPS was verified by denaturing electrophoresis (A) and its function was confirmed 
with native activity staining (B).  
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0 h: Incubated for o h after added with IPTG 
1 h: Incubated for 1 h after added with IPTG  
2 h: Incubated for 2 h after added with IPTG 
 
Fig. 20. Cyclic dipeptides increased in culture filtrates of recombinant CDPS. To 
confirm the induction of cyclic dipeptides in transfected E .coli culture, HPLC analysis 
of culture extracts were performed. The result indicate, the most important functional 





0 h: Incubated for o h after added with IPTG 
1 h: Incubated for 1 h after added with IPTG 
2 h: Incubated for 2 h after added with IPTG 
 
Fig. 21. Overall profiles of the increased production of cyclic dipeptides using 
HPLC system in CDPS gene transfected bacteria.  
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MCK10: Culture supernatant of Lb. plantarum LBP-K10 were extracted by methylene chloride (MC). 
MC3aCDPS:  Culture supernatant of recombinant E. coli with CDPS were extracted by MC. 
MC3a: Culture supernatant of recombinant E. coli without CDPS were extracted by MC. 
MCE.coli: Culture supernatant of E. coli without CDPS were extracted by MC. 
 
Fig. 22. MC extract of transfected E. coli medium showed enhanced antibacterial 
activity. After transfected with CDPS plasmid, the antimicrobial activity of MC extract 
from E. coli was increased and was comparable with MCK10. However, the extract from 
control plasmid transfected or intact E. coli display a weak or negligible effect on the 
bacteria indicators.   
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4. 3. 4. Detection of cyclic dipeptides produced by purified enzyme 
To confirm the recombined over expressed CDPS was functional, cyclic dipeptide 
synthesis activity was tested in vitro or in vivo. CDPS were purified with superdex 75 
chromatogram and collected every hour. Each fraction run on SDS-page the over 
expressed 25 kDa band were confirmed. Consistent with our previous results, F9 
fraction contains the most enriched CDPs (Fig. 23A).  Synthesis function analysis 
followed by ninhydrin staining of purified CDPS were performed as described as 
before. Through the enzyme reaction and consecutive activity staining, the active bands 
where CDPS located showed transparent grey color while the background generally 
present blue color (Fig. 23B). The presence of cyclic dipeptides synthesized by purified 
enzyme in vitro was further confirmed by HPLC. In HPLC analysis conditions, the 
impurity or solvent peaks were detected within ten min. Moreover, the retention time 
of cyclic dipeptides stands were always shown up longer than 10 min. Therefore, the 
peaks which were detected by HPLC chromatogram with a retention time more than 
10 min were regarded as cyclic dipeptides or other byproducts through the enzyme 
reactions. These results indicate that the predicted cyclic dipeptide fractionation driven 
by the enzyme reactions could be performed. Because the optimal temperature for 
bacteria biological activities is 37 °C and the activity of CDPS was ATP-dependent, 
pH valve of the reaction solution might be the most important factor to be concerned 
in the reaction conditions. Therefore, several pH conditions were intensively examined 
using each amino acid combinations including L-Proline and L-Lysine, L-Proline and 
L-Phenylalanine, L-Proline and L-Serine. The amount of the cyclic dipeptides 
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produced by enzyme reactions in the in vitro condition was measured by HPLC 
chromatograms. Interestingly, the most efficient pH values for enzyme activity were 
delicately different by the amino acids combination-dependent manner. Therefore, 
CDPS activity was significantly higher in pH 8 than in other pH. pH 8 was the most 
optimal reaction pH condition for the production of cyclo(Pro-Lys) and cyclo(Pro-Val) 
with the highest peak of cyclic dipeptide presented on the HPLC spectra (Fig. 24-1, 
Fig. 24-4) contrast to the low activity at pH 6 for producing cyclo(Pro-Ser) (Fig. 24-3). 
When comparing to reference experiments, HPLC chromatograms explained that 
CDPS could contribute to the generation each cyclic dipeptide such as Pro-Lys, Pro-
Phe, Pro-Val, Pro-Ser and Pro-Leu) (Fig. 24). 
To confirm the peaks in HPLC represented are cyclic dipeptides, we collected each 
compound according each peak, and then subjected them for GC/MS analysis using 
electron ionization and chemical ionization. With the reference we have obtained from 
the data base and the compound isolated from lactic acid before, we concluded that 
cyclo(Phe-Phe) and cyclo(Pro-Phe) could be generated in the reaction system including 
L-Proline and L-Phenylalanine (Table 15-1), cyclo(Pro-Lys) and cyclo(Lys-Lys) could 
be found in the reaction system including L-Proline and L-Lysine (Table 15-2), 
cyclo(Pro-Ser) in the system including L-Proline and L-Serine (Table 15-3), cyclo(Pro-
Val) in the system including L-Proline and L-Valine. However, we could not exclude 
the possibility of the existing of other kind of cyclic dipeptides, which could be 
undetectable due to small amount or inefficiency ionization.  
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Fig. 23. Purification and activity assay of Recombinant CDPS. After gel filtration 
with superdex75 column chromatography, recombined CDPS were confirmed on SDS-
PAGE (A). Activity of purified CDPS were checked using native staining assay (B).  
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Fig. 24-1. HPLC analysis confirmed CDPS that catalyzed the synthesis of 
cyclo(Pro-Lys) in vitro. CDPS catalyzes two amino acid pairs, such as L-Proline and L-
Lysine, to generate cyclo(Pro-Lys) in vitro. The chromatograms peaks of L-Proline 
(upper left), L-Lysine (left right), ATP (middle left) and CDPS (lower left) were shown 
as indicated. In the case of the reaction mixture of L-Proline, L-Lysine and ATP, it did 
not show CDPs peaks within 10 min (middle right). However, when CDPS was added 
to the reaction mixture, the biosynthesized cyclo(Pro-Lys) and cyclo(Lys-Lys) (as 
indicated in the figure) was observed as new peaks ranging from 16.5-16.7 min.  
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Fig. 24-2. HPLC analysis confirmed CDPS that catalyzed the synthesis of 
cyclo(Pro-Phe) in vitro. CDPS catalyzes two amino acid pairs, such as L-Proline and L-
Lysine, to generate cyclo(Pro-Lys) in vitro. L-Proline (upper left), L-Lysine (left right), 
ATP (middle left) and CDPS (lower left) peaks were shown as indicated. In the case of 
the reaction mixture of L-Proline, L-Lysine and ATP, it did not show CDPs peaks within 
10 min (middle right). However, when CDPS was added to the reaction mixture, the 
biosynthesized cyclo(Pro-Phe) and cyclo(Phe-Phe) was observed as new peaks ranging 
from 15.5-26 min. 
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Fig. 24-3. HPLC analysis confirmed CDPS that catalyzed the synthesis of 
cyclo(Pro-Ser) in vitro. L-Proline (upper left), L-Serine (left right), ATP (middle left) 
CDPS (lower left) peaks were shown in HPLC chromatogram. The reaction mixture of 
L-Proline, L-Serine and ATP presented no peaks after ten min (middle right). However, 






Fig. 23-4. HPLC analysis confirmed CDPS that catalyzed the synthesis of 
cyclo(Pro-Val) in vitro. L-Proline (upper left), L-Valine (left right), ATP (middle left) 
CDPS (lower left) peaks were shown in HPLC chromatogram. The reaction mixture of 
L-Proline, L-Valine and ATP presented no peaks after ten min (middle right). However, 
when CDPS was added, the reaction mixture of L-Proline, L-Valine, ATP and cyclic 
dipeptides showed a peak of new substance [which was confirmed as cyclo(Pro-Val)] 
later on around 13 min.  
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Fig. 23-5. HPLC analysis confirmed CDPS that catalyzed the synthesis of 
cyclo(Pro-Val) in vitro. L-Proline (upper left), L-Leucine (left right), ATP (middle left) 
CDPS (lower left) peaks were shown in HPLC chromatogram. The reaction mixture of 
L-Proline, L-Leucine and ATP presented no peaks after ten min (middle right). However, 
when CDPS was added in, the reaction mixture of L-Proline, L-Leucine, ATP and cyclic 
dipeptides showed a peak of new substance around 19 min.  
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Table 15-1 Mass analysis of products reacted with L-Proline and L-Phenylalanine 
 m/z of 
[M+1+ 
m/z (%) of EI-MS molecules 
 
488 
489.8(5.8), 488.9(17.8), 367.6(8.5), 337(3.5), 
325(18.4), 249(6.4), 205(10.4), 163(40.1), 
155.0 (2.45), 136(6.2),125.1 (2.2), 119(100), 






295 (10), 267 (7.4), 239(17.8), 129 (34.2), 






Table 15-2 Mass analysis using EI and CI by GC-MS of products reacted with L-Proline 
and L-Lysine 
 m/z of 
[M+1+ 
m/z (%) of EI-MS Predicted molecules 
 
      
  225 
  256 (67.8), 241 (23.9), 213(38.7), 185 
(42.2), 171 (27), 157 (20.9),    129(69.3), 
115 (24.1), 111 (21.6), 97 (38.4), 85 (41.3), 83. 




  256 
  256 (67.8), 241 (23.9), 213(38.7), 185 
(42.2), 171 (27), 157 (20.9),    129(69.3), 
115 (24.1), 111 (21.6), 97 (38.4), 85 (41.3), 83. 









m/z (%) of EI-MS molecules 
 197.0 
197 (7.1), 183. (6.6), 167.1 (6.9), 155.1 (11), 
140.1 (5.0), 139.1 (6.0),  
 137.1 (17.1), 125.5 (7.8), 114.4 (4.9), 113.4 
(16.5), 112.4 (19.4), 111.4 (24.6.), 110.4 (6.1), 
107.3 (7.9), 99.4 (20.7), 98.3 (8.6), 97.1 (20.8), 
96.3 (9.6), 84.1 (15.6), 83.1 (24.5), 82.1 (14.7), 
73.2 (8.2), 72.3 (5.2), 71.1 (61.4), 70.3 (23.5), 










m/z (%) of EI-MS molecules 
 185.0 
155.0 (12), 149.0 (12.7), 141.0 (8.6), 129.0 (13), 
127.0 (15.4), 113 (10.8), 112.0 (11), 99.0 (12.5), 
98.0 (8.1), 93.0 (10.6), 85.0 (29), 84.0 (9.9), 
83.0 (27.1), 71.1 (31.8), 70.1 (18.9), 60.0 (14.4), 
57.0 (73.1), 56.0 (10.9), 55.0 (30.2) 
cis-cyclo(L-Ser-L-
Pro),  C8H12N2O3 
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Table 15-5 Mass analysis using EI and CI by GC-MS of products reacted with L-Proline 
and L-Leucine 
 m/z of 
[M+1+ 
m/z (%) of EI-MS molecules 
 195.0 
195 (0.9), 184 (3.3), 178 (2.4), 155.1 (18.5), 
154.1 (100.0), 153.1 (1.5), 138 (8.5), 129.1 
(35.6), 111.1 (11.4), 100.1 (16.4), 90 (57), 84 







4. 3. 5. Molecular mass of CDPS in solution 
     To confirm the oligomeric state, purified CDPS protein (Fig. 25) was applied on 
Superose 12 10/300 GL column (GE Healthare) with molecular mass standards.  A 
standard curve was generated by plotting the logarithm of melecular mass of standard 
proteins against their Kav, where kav= (Ve-Vo)/(Vt-Vo): Ve, elution volume; Vo, void 
volume; Vt, total ved volume. Kav of CDPS determined by using the same column was 
compared to the profile of protein standards; predicted molecular mass of CDPS is 99.18 




Fig. 25. Molecular mass was confirmed with superose 12 gel permeation column 
(GE Healthcare) for determining the oligomeric state. Superpose 12 gel permeation 
column used for determine the molecular weight with the standard contrast of aprotinin, 
cytochrome C, Albumin, and alcohol dehydrogenase (A). According the results of 
FPLC, the molecular of CDPS was calculated as 99.18 kDa (C). Purified CDPS was 
confirmed with 12 % SDS-PAGE as 25 kDa (B).   
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4. 3. 6. Structural determination of CDPS 
To better understand the structure of CDPs, X-ray analysis was performed. Crystal 
native data sets and Se-Met substituted were collected at 100 K with area detector 
Systems Corporation (ADSC) Quantum 210 charge-coupled device area detector system 
at BL-7A at Pohang Light Source (PLS), South Korea. Diffraction data were processed 
and scaled with program DENZO and SCALEPACK (Otwinowski and Minor). Crystals 
belongs to the monoclinic space group, c2, with unit-cell parameters a=234.63, b=63.60, 
c=70.43 Å, and β=94.17. The solvent content of crystal was 39.3 % when the asymmetric 
unit is assumed to contain one molecule (Matthews 1968). 
The four selenium sites were located (data not shown), and phase refinement was 
done by using the programs SOLVE and RESOLVE (Terwilliger 1999, Terwilliger and 
Berendzen 1999). Initial phasing and model building was with Se-Met CDPS MAD data 
set. Model building was done using the program COOT software (Emsley et al. 2010) 
and refined with REFMAC5 (Murshudov et al. 1997) from the CCP4 program suite 
(Collaborative Computational Project, 1994). Single crystal of CDPS was made in 50 
mM MgCl2, 100 mM HEPES pH 7.5 and 17 % PEG550 (Fig. 26) The native CDPS 
structure was refined to Rwork of 39.3 and Rfree of 11.6 in the resolution range of 5.0-2.08 
Å. The refinement statistics of the native CDPS structure are summarized in Table 16. 
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Table 16 Data collection and refinement statistics of CDPS 
 Native CDPS data 
Wavelength (Å) 1 
Temperature (K) 100 
Resolution (Å) 0 2.08 
Space group C2 
Unit cell parameters 
a=234.63, b=63.60, c=70.43 
, α=90, β=94.17, γ=90 
Detector distance (mm) 300 
Rotation range per image (°) 1 
Exposure time per image (sec) 3 
Total rotation range (°) 250 
Completeness (%)a 80.9 
Mean (I) 12.1 
Rsym (%)a,b 39.3 
Refinement  
Redundancy 2.8 (1.5) 
Total reflections 138,245 
Rc (R free) (%) 11.6 (39.3) 
a. The number in parentheses is for the outer shell. 
b. Rsym=ΣhΣI⁄Σh,i-Ih⁄ΣhΣIIh,i  where Ih is the mean intensity of the I observations of 
symmetry related reflections of h. 
c. R=Σ/Fo-Fc/ΣFO, where Fo=Fp, and Fc is the calculated protein structure factor 
from the atomic model. Rfree was calculated with 10 % of the reflections. 
d. R=Σ/Fo-Fc/ΣFO, where Fo=Fp, and Fc is the calculated protein structure factor 







Fig. 26. Crystals and diffraction images of CDPS. 
A: The crystals of CDPS. 
B: The diffraction image of CDPS of X-ray radiation.  
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4. 3. 7. Overall Structural of Recombined CDPS 
According to the ribbon model of the CDPS as shown as Figure 27, CDPS was 
composed as a tetramer structure with 4 identical subunits. In terms of the secondary 
structure, the subunit has 3 main layers of alpha/beta/alpha (Fig. 28). It contains a mixed 
bate sheet of 6 strands with one strand existing as an anti-parallel strand to the rest. 
Totally 7 alpha helix and 5 310 helix surround the beta sheet layer. Four subunits 
polymerized together symmetrically and form a hollow space in the center (Fig. 29). The 
similar binding site were searched through PDBj database (http://pdbj.org/giraf/). 
Interestingly the result reveal the sequence of CDPS are comparable with human 
phosphoglycerate mutase 1 (PGM1), a member of alkaline phosphatase superfamily, 
with a similarity score of 74 % (Fig. 30). Noticeably, except PGM enzyme of yeast which 
is a homotetramer of mass 110,000 kDa, PGM enzymes are usually homodimer 
molecular. Thus, we confirmed CDPS isolated from lactic acid bacterial is a novel 





Fig. 27. The homotetramer structure of CDPS. As shown in the new cartoon model, 







Fig. 28. The secondary structure of CDPS subunit. For a better view, the subunit A 
were colored depended on the secondary structure (left panel). Each of the identical 
subunits contains 6 beta sheets (yellow), surrounded by 7 alpha helix (purple) and 5 310 




Fig. 29. A hollow space centered in the structure of CDPS (Arrow). A hollow space 






Fig. 30. Comparation of cyclic dipeptide synthetase and PGM1 (PDBID: 1YFK). 
Through PDBj data base, it is confirmed cyclic dipeptide synthetase contains the similar 
combining site with human PGM1.  
 
  124
4. 4. Discussion 
Unwiring the structure and function of CDPS is pivotal for revealing the 
physiological processing of CDPs synthesis in microorganism as well as inventing in 
vitro bioreactor for producing functional CDPs. In this study, we identified a kind of new 
CDPS protein which displayed the capability of synthesis antibiotic CDPs, especially 
proline based CDPs. When transferring this gene into E. coli, functional CDPS could be 
obtained. Moreover, with HPLC confirmation, we successfully defined an in vitro 
reactions system which consisted with CDPS, amino acid, ATP in PBS buffer solutions. 
We figured out that, in 37 °C and ATP supplement, CDPS could synthesize the target 
CDPs.  However, compare with the in vivo system, the synthesizing efficacy was quite 
low. This may indicate that for higher yield of CDPs, other auxiliary molecular may be 
needed besides more optimal physiochemical conditions should be defined. Moreover, 
we noticed CDPS especially catalyze the synthesis of CDPs with proline based DZK 
ring structure. 
We further analyzed the 3 dimensional structure of CDPS by X-ray crystallographic 
analysis (data not shown). We are now working for identify the catalytic site in order to 
reveal the synthesis process in more detail. 
As a conclusion, it was firstly reported the CDPS like function of an unnamed protein 
(gi311821850), and successfully development the in vitro CDPs synthesis conditions 
based on the newly found CDPS protein, CDPS. These studies will contribute to 
producing CDPs in vitro through biosynthesis pathway and to discover physiology 













Studies elucidate CDPs produced by LAB were important for their probiotic effect 
on human health. In this study, we firstly extract CDPs with MC. The filtrates were 
separated on anion exchangers by applying them to a combination of the weakly basic 
or strongly basic anion resins Amberlite IRA-67 and Purolite A420S, respectively. 
Organic acids and sugars, were removed using three types of anion exchange 
chromatography. The resultant eluents were extracted with MC as a secondary 
purification step. The MC-extracted samples were reseparated by HPLC and a combined 
fraction including F1 to F17 was obtained. Additionally, owing to the repeated MC 
extraction during the purification steps, the eluents contained pure CDPs. All of the 
CDPs with activity against bacteria, fungi and viruses, including cis-cyclo(L-Val- L-Pro) 
(F7), cis-cyclo(L-Leu- L-Pro) (F13) and cis-cyclo(L-Phe- L-Pro) (F17), significantly 
increased in the stationary phase of cell growth. This observation coincided with the 
increase in antifungal fractions, including cis-cyclo(L-Tyr- L-Pro) (F6), cis-cyclo(L-
Val- L-Pro) (F7), cis-cyclo(L-Ser- L-Pro) (F9), cis-cyclo(L-Leu- L-Pro) (F12) and cis-
cyclo(L-Phe- L-Pro) (F17). HPLC profile of the total pool of CDPs naturally produced 
by the isolates showed an identical pattern. 
Although many studies investigated the anticancer activities of LAB, its effect on 
non-GI tract cancer has been rarely studied. Since the absorption of CDPs was proved 
previously and the stability of its special chemical structure, we expect LAB are capable 
of inhibiting the growth of breast cancer.  In this study, the cancer prevention effect of 
Lb. plantarum LBP-K10 were confirmed first on in situ breast cancer model in mice by 
oral administration of cell free CF-K10. CF-K10 may induced apoptosis in breast cancer 
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cell line MDA-MB-231 by activation apoptosis pathways. The expression of caspase-3 
and cytosolic cytochrome C were elevated when the cells treated with MC-K10. Ac-
DEVD-CHO, an inhibitor of caspase-3 reversed apoptosis effect of MC-K10 treatment. 
These results indicate MC-K10 isolated from CF-K10 could induce breast cancer cell 
apoptosis through caspase-3 pathway. The sphere formation ability and partition of 
CD133+ cells were decrease dramatically in MC-K10 treated group thought the decease 
of sphere formation ability and CD133+ cell partition were milder in cyclo(Phe-Pro) 
administration group. Compare with cyclo(Phe-Pro) treatment, the expression of Oct4 
was also dramatically down regulated in MC-K10 treated group. These results indicated 
MC-K10 could induce the stemness and self-renew ability of breast cancer stem cells. 
These results provided new insight for the probiotic active of LAB, and also contribute 
to develop new strategies for breast cancer privation. 
These studies revealed as a nature product form LAB, CDPs has great potential in 
antibiotic or even anti cancer activites. The special and rigid structure of CDPs were also 
attracted great attention for developing new drugs. Therefore, we next tried to reveal the 
machanism of CDPs synthesis in Lb. plantarum LBP-K10, so that we can increase the 
level of CDPs content in Lb. plantarum LBP-K10 or develop methods for synsthesis 
CDPs in vitro. In this study, a new CDPS was identified. When transfecting this gene 
into E. coli, CDPs production were upregulated, especially CDPs with L-proline based 
diketopiperazine ring structure. Moreover, confirmed by HPLC, cyclic dipeptides were 
also successfully obtained in an in vitro reaction system which consisted with 
recombined CDPS, amino acid, ATP in buffer solutions. Several pH conditions were 
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tested in each amino acid combinations (L-Proline and L-Lysine; L-Proline and L-
Phenylalanine; L-Proline and L-Valine; L-Proline and L-Serine; L-Proline and L-
Leucine) and the amount of the cyclic dipeptides producing in the in vitro condition was 
measured by HPLC. However, compare with the in vivo system, the synthesizing 
efficacy was quite low. It may indicate that for higher yield of cyclic dipeptides, other 
auxiliary molecular may be needed, or more optimal physiochemical conditions should 
be defined. In order to better understand that the mechanism of cyclic dipeptides 
synthesis in molecular level, we analyzed the 3 dimensional structure of CDPS by X-ray 
crystallographic analysis. CDPS was composed as a tetramer structure with 4 identical 
subunit showed in the ribbon model. Thus, it was confirmed that CDPS isolated from 
Lb. plantarum LBP-K10 was a novel member of alkaline phosphatase superfamily. We 
are now further working for identify the catalytic site in order to reveal the synthesis 
process in more detail. 
 Above of all, antimicrobial CDPs produced by Lb. plantarum LBP-K10 were 
purified and characterized. Totally eight antibiotic components were identified. Also, a 
massive purification method was proposed. CDPs complex produced by Lb. plantarum 
LBP-K10 are capable of prevention breast cancer by targeting cancer stem cells. The 
CDPS like function of an unnamed protein (gi311821850) was firstly reported and it was 
successfully used as developed the in vitro cyclic dipeptides synthesis conditions. This 
study provided new insight for understanding the probiotic effect and applications of 
LAB. It was also contribute for developing new strategies for generating CDPs more 
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유산균 (LAB)은 인간의 건강을위한 프로 바이오 틱 미생물로 인정 받고 
있다. LAB 에 의해 생성 된 사이클릭 디 펩티드 (CDP 가)는 자신의 항생제 
활동에 중요하다. CDP 가 디케 토피 페라 (diketopiperazine) 구조의 여러 
종류의 분자의 그룹이고, 약물 설계를 위한 매력적인 골격을 역임한다. 
이러한 항생 활성 물질로서. 유산균 배양액 내의 CDP 성분이 보고된 바가 
미미하며 한 균주에서 모든 CDP 를 규명한 보고가 없었다. 따라서 본 
연구는 락토바실러스 플라타륨 LBP-K10 (Lactobacillus plantarum LBP-K10) 
에서 생산되는 항생 CDP 를 복합체 형태로 분리하고 각각의 CDP 를 
순수분리하여 이를 확인하여 항생 활성에 대하여 관찰하였다. 모두 일곱 
CDP 가 가스 크로마토 그래피 - 질량 분석을 통해 확인 하였다. 음이온 
교환 수지인 Amberlite IRA-67 와 Purolite A420S 를 사용하여 column 
chromatographs 를 통해 배양액 여과액에 있는 모든 CDP 를 대량 분리하는 




인간 및 식물 특이성을 가지는 병원성 진균과 인플루엔자 바이러스에 
대해서 단일 싸이클릭 디펩티드와 비교하여 볼 때 수십배의 활성 상승 
효과를 보였다. 
최근 연구는 가지 메커니즘에 의해 암 진행을 억제 할 수도있는 유산균 
또는 생산물을 밝혔다. 그러나 대부분의 연구는 위장관 관련 암, 특히 
결장암에 초점을 맞춘다. 비 위장관 암에 관련 유산균 또는 생산물의 
효과가 거의 관찰되지 않았다. CDP가 효율적으로 흡수 입증하기 때문이라는 
연구가 있어, 유산균이 비 - 위장관 암의  일종인 유방암에 대한 암 예방 
효과조사 하였다. LBP-K10 배양 여액에서 주로 CDP 를 포함한 메틸렌 
클로라이드 추출 분획 (MC-K10)를 동정하였다. 본 연구에서는, 경구 적용 
CF-K10 동물 모델에서 유방암 성장의 진행을 억제하는 것으로 처음으로 
확인되었다. 또한 CF-K10 및 MC-K10 는 MDA-MB-231 세포에서 세포 
사멸을 유도 할 수 있음을 발견했다. 또한, 암 줄기 세포의 stemness 와 자가 




하였고. 이연구들은 새로운 LAB 및 제품의 프로바이오틱스 활성에 대한 
통찰력과 유방암 예방 전략의 개발을 위한 힌트를 제공을 제공한다. 
인간의 히스에 CDP 가의 중요성과 이점은 CDP 생합성 과정을 
조사하기를 격려했다. 닌히 드린 활성 염색에 의해, 싸이클릭딥펩티드 합성 
효소 (CDPS)에 의존 경로를 통해 Lb. plantarum LBP-K10 에서 
활성물질인 CDP 를 합성함을 확인할 수 있었다. Lb. plantarum LBP-K10 에서 
순수분리된 CDPS 는 2D LC MS/MS 를 사용하여 분자량과 단백질의 이차 
구조를 예측할 수 있었다. 락토바실러스 플란타룸 LBP-K10 의 CDPS 는 
분자량이 26.1 kDa 이며 (gi311821850) 690 bp 의 open reading frame 을 유전자 
서열을 가짐을 확인하였다. 흥미롭게도, 이 CDPS 유전자를 대장균에 
형질전환을 수행한 결과, 다양한 형태의 proline 을 가지는 CDP 의 발현이 
증가함을 관찰하였다. 이와 동시에 대장균에 형질전화한 CDPS 의 발현은 
SDS-PAGE 에서 CDP 를 합성하는 최적의 in vitro 조건도 동시에 확인할 수 
있었다. 또한 분자 수준에서 CDP 를 합성기전을 이해하기 위해서 효소를 x- 
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선 회절 분석을 수행하였다. 결정은 2.6 Å 의 해상도로 분석하였고 C2 space 
group 이며 리본모델에서 CDPS 가 4 개 동일한 서브유닛과 사양구조로 
보였다. 본 연구는 처음으로 새로운 CDPS 를 동정하며 CDPS 가 CDPs 를 
생성하는 체외(in vitro)조건을 확인하였다. 본 연구는 체외에서 자연 항생제 
CDP 를 생합성 하는 메커니즘과 과정을 이해하는 데 도움이 될 것이다. 
무엇보다도, 이러한 연구들에서 Lb. plantarum LPB-K10 에 
전체는 CDPS 프로파일 식별하였으며, 유산균과 유산균이 생산한 CDP 들의 
암 예방 효과를 입증하였고, CDPS 를 처음으로 동정하였다. 이 연구는 
CDP 가 생합성 메커니즘을 이해하기위한 프로 바이오 틱 유산균과 그의 
혜택에 새로운 통찰력을 제공하였다. 
주요어: 사이클릭 디 펩티드, 싸이클릭딥펩티드 합성 효소, 락토바실러스 
플라타륨LBP-K10, 유방암, 암 예방, 암 줄기 세포, 다제내성균, 병원성 진균, 
인플루엔자 바이러스, 시클로 페닐알라닌 
